<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85140</article-id><article-id pub-id-type="doi">10.7554/eLife.85140</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title><italic>Plasmodium falciparum</italic> adapts its investment into replication <italic>versus</italic> transmission according to the host environment</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-32380"><name><surname>Abdi</surname><given-names>Abdirahman I</given-names></name><email>aabdi@kemri-wellcome.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299828"><name><surname>Achcar</surname><given-names>Fiona</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8792-7615</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-98634"><name><surname>Sollelis</surname><given-names>Lauriane</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-242597"><name><surname>Silva-Filho</surname><given-names>João Luiz</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4762-2205</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299838"><name><surname>Mwikali</surname><given-names>Kioko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299839"><name><surname>Muthui</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299857"><name><surname>Mwangi</surname><given-names>Shaban</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1961-3205</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299858"><name><surname>Kimingi</surname><given-names>Hannah W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299859"><name><surname>Orindi</surname><given-names>Benedict</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299860"><name><surname>Andisi Kivisi</surname><given-names>Cheryl</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166412"><name><surname>Alkema</surname><given-names>Manon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8906-0047</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299861"><name><surname>Chandrasekar</surname><given-names>Amrita</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299862"><name><surname>Bull</surname><given-names>Peter C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9838"><name><surname>Bejon</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299863"><name><surname>Modrzynska</surname><given-names>Katarzyna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-84667"><name><surname>Bousema</surname><given-names>Teun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2666-094X</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-75511"><name><surname>Marti</surname><given-names>Matthias</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1040-9566</contrib-id><email>matthias.marti@glasgow.ac.uk</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04r1cxt79</institution-id><institution>KEMRI-Wellcome Trust Research Programme</institution></institution-wrap><addr-line><named-content content-type="city">Kilifi</named-content></addr-line><country>Kenya</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02952pd71</institution-id><institution>Pwani University Biosciences Research Centre, Pwani University</institution></institution-wrap><addr-line><named-content content-type="city">Kilifi</named-content></addr-line><country>Kenya</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00vtgdb53</institution-id><institution>Wellcome Center for Integrative Parasitology, University of Glasgow</institution></institution-wrap><addr-line><named-content content-type="city">Glasgow</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>Institute of Parasitology, Vetsuisse and Medical Faculty, University of Zurich</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05wg1m734</institution-id><institution>Radboud University Nijmegen Medical Centre</institution></institution-wrap><addr-line><named-content content-type="city">Nijmegen</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Soldati-Favre</surname><given-names>Dominique</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01swzsf04</institution-id><institution>University of Geneva</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85140</elocation-id><history><date date-type="received" iso-8601-date="2022-11-24"><day>24</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-01"><day>01</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-12-02"><day>02</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.29.518379"/></event></pub-history><permissions><copyright-statement>© 2023, Abdi et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Abdi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85140-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-85140-figures-v2.pdf"/><abstract><p>The malaria parasite life cycle includes asexual replication in human blood, with a proportion of parasites differentiating to gametocytes required for transmission to mosquitoes. Commitment to differentiate into gametocytes, which is marked by activation of the parasite transcription factor <italic>ap2-g</italic>, is known to be influenced by host factors but a comprehensive model remains uncertain. Here, we analyze data from 828 children in Kilifi, Kenya with severe, uncomplicated, and asymptomatic malaria infection over 18 years of falling malaria transmission. We examine markers of host immunity and metabolism, and markers of parasite growth and transmission investment. We find that inflammatory responses associated with reduced plasma lysophosphatidylcholine levels are associated with markers of increased investment in parasite sexual reproduction (i.e. transmission investment) and reduced growth (i.e. asexual replication). This association becomes stronger with falling transmission and suggests that parasites can rapidly respond to the within-host environment, which in turn is subject to changing transmission.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>malaria</kwd><kwd>transmission</kwd><kwd>adaptation</kwd><kwd>host parasite interaction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>Plasmodium falciparum</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>110166</award-id><principal-award-recipient><name><surname>Achcar</surname><given-names>Fiona</given-names></name><name><surname>Sollelis</surname><given-names>Lauriane</given-names></name><name><surname>Silva-Filho</surname><given-names>João Luiz</given-names></name><name><surname>Marti</surname><given-names>Matthias</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>104111</award-id><principal-award-recipient><name><surname>Achcar</surname><given-names>Fiona</given-names></name><name><surname>Sollelis</surname><given-names>Lauriane</given-names></name><name><surname>Silva-Filho</surname><given-names>João Luiz</given-names></name><name><surname>Marti</surname><given-names>Matthias</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>Wolfson Merit Award</award-id><principal-award-recipient><name><surname>Marti</surname><given-names>Matthias</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bousema</surname><given-names>Teun</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>209289/Z/17/Z</award-id><principal-award-recipient><name><surname>Abdi</surname><given-names>Abdirahman I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>We investigate how parasites adapt to environmental changes in the context of changing transmission patterns, for example by increasing investment in transmission stages at low endemicity such as elimination settings.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Malaria remains one of the world’s major public health problems. In 2021, an estimated 619,000 deaths and 247 million cases were reported (<xref ref-type="bibr" rid="bib65">WHO, 2022</xref>). Around 70% of deaths are in African children under five years of age and are caused by a single parasite species, <italic>Plasmodium falciparum</italic> (<xref ref-type="bibr" rid="bib65">WHO, 2022</xref>).</p><p><italic>P. falciparum</italic> has a complex life cycle, involving obligatory transmission through a mosquito vector and asexual replication within erythrocytes of the human host. Between-host transmission requires the formation of gametocytes from asexual blood stage forms, as gametocytes are the only parasite stage to progress the cycle in the mosquito. A series of recent studies has demonstrated that commitment to gametocyte formation (i.e. stage conversion) is epigenetically regulated and occurs via activation of the transcription factor, AP2-G that in turn induces transcription of the first set of gametocyte genes (<xref ref-type="bibr" rid="bib24">Kafsack et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Sinha et al., 2014</xref>).</p><p>The parasites that do not convert into gametocytes continue to replicate asexually, contributing to within-host parasite population growth (i.e. parasite burden) and determining <italic>P. falciparum</italic> infection outcome that ranges from asymptomatic infections to severe complications and death (<xref ref-type="bibr" rid="bib33">Marsh and Snow, 1999</xref>; <xref ref-type="bibr" rid="bib27">Langhorne et al., 2008</xref>; <xref ref-type="bibr" rid="bib64">White, 2018</xref>). Cytoadhesion of infected erythrocytes (IE) to receptors on microvascular endothelium of deep tissues reduces the rate of parasite elimination in the spleen (<xref ref-type="bibr" rid="bib46">Rowe et al., 2009</xref>; <xref ref-type="bibr" rid="bib60">Turner et al., 2013</xref>), thus supporting the within-host expansion of the parasite population (i.e. parasite burden). As a side effect of this parasite survival strategy, cytoadhesion reduces the diameter of the vascular lumen, thus impairing perfusion and contributing to severe malaria pathology (<xref ref-type="bibr" rid="bib51">Silamut et al., 1999</xref>; <xref ref-type="bibr" rid="bib58">Taylor et al., 2004</xref>; <xref ref-type="bibr" rid="bib20">Hanson et al., 2012</xref>). <italic>P. falciparum</italic> erythrocyte membrane protein 1 (PfEMP1), encoded by the <italic>var</italic> multi-gene family, plays a critical role in both pathogenesis (through cytoadhesion) (<xref ref-type="bibr" rid="bib53">Smith et al., 1995</xref>; <xref ref-type="bibr" rid="bib56">Su et al., 1995</xref>) and establishment of chronic infection (through variant switching and immune evasion) (<xref ref-type="bibr" rid="bib42">Recker et al., 2004</xref>; <xref ref-type="bibr" rid="bib49">Scherf et al., 2008</xref>).</p><p>Both <italic>var</italic> gene transcription and stage conversion (and hence <italic>ap2-g</italic> transcription) are subject to within-host environmental pressures such as immunity (<xref ref-type="bibr" rid="bib44">Rono et al., 2018</xref>), febrile temperature (<xref ref-type="bibr" rid="bib37">Oakley et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Rawat et al., 2021</xref>), nutritional stress (<xref ref-type="bibr" rid="bib10">Carter and Miller, 1979</xref>), and drugs (<xref ref-type="bibr" rid="bib8">Buckling et al., 1999</xref>), perhaps via a common epigenetic regulation mechanism (<xref ref-type="bibr" rid="bib14">Coleman et al., 2014</xref>). For example, in vitro studies revealed that stage conversion can be induced by nutritional depletion such as spent culture media (<xref ref-type="bibr" rid="bib10">Carter and Miller, 1979</xref>; <xref ref-type="bibr" rid="bib66">Williams, 1999</xref>) and depletion of Lysophosphatidylcholine (LPC) (<xref ref-type="bibr" rid="bib7">Brancucci et al., 2017</xref>). Recent work from Kenya and Sudan provides some evidence that parasites in low relative to high transmission settings invest more in sexual commitment and less in replication and <italic>vice versa</italic> (<xref ref-type="bibr" rid="bib44">Rono et al., 2018</xref>). Altogether these studies suggest that the parasite can sense and rapidly adapt to its environment in vitro and in vivo. A family of protein deacetylases called sirtuins is known to link environmental cues to various cellular processes via metabolic regulation (<xref ref-type="bibr" rid="bib30">Li, 2013</xref>; <xref ref-type="bibr" rid="bib6">Bosch-Presegué and Vaquero, 2014</xref>; <xref ref-type="bibr" rid="bib62">Vasquez et al., 2017</xref>). They do this through epigenetic control of gene expression (<xref ref-type="bibr" rid="bib62">Vasquez et al., 2017</xref>) and post-translational modification of protein function (<xref ref-type="bibr" rid="bib62">Vasquez et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Zhu et al., 2012</xref>). The <italic>P. falciparum</italic> genome contains two sirtuins (Pfsir2a/b) which have been linked to the control of <italic>var</italic> gene transcription (<xref ref-type="bibr" rid="bib59">Tonkin et al., 2009</xref>; <xref ref-type="bibr" rid="bib34">Merrick et al., 2012</xref>), and their expression is influenced by febrile temperature (<xref ref-type="bibr" rid="bib37">Oakley et al., 2007</xref>) and low transmission intensity (<xref ref-type="bibr" rid="bib44">Rono et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">O’Meara et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Mogeni et al., 2016</xref>).</p><p>Here, we investigated the interplay between parasite and host environmental factors governing parasite investment in reproduction (to maximize between-host transmission) <italic>versus</italic> replication (to ensure within-host persistence) in vivo. We analyzed samples and clinical data collected from children in Kilifi county, Kenya, over changing malaria transmission intensity between 1994 and 2014. We quantified parasite transcripts for <italic>ap2-g</italic>, <italic>PfSir2a,</italic> and <italic>var</italic> genes, as well as <italic>Pf</italic>HRP2 protein levels (for parasite biomass) and levels of host inflammatory markers and lipid metabolites. We then integrated these host and parasite-derived parameters to interrogate their dynamics and interactions in the context of changing transmission intensity and immunity.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>A clinical malaria patient cohort across changing transmission periods in Kilifi, Kenya</title><p>The study included samples and clinical data collected from 828 children from Kilifi county, Kenya, over 18 years of changing malaria transmission (<xref ref-type="bibr" rid="bib38">O’Meara et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Mogeni et al., 2016</xref>). The study period encompassed three defined transmission phases: pre-decline (1990–2002), decline (2003–2008), and post-decline (2009–2014) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). During the study period, a total of 26,564 malaria admissions were recorded at Kilifi county hospital (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). While the number of parasite-positive admissions decreased, the mean patient age at admission increased over time (<xref ref-type="bibr" rid="bib33">Marsh and Snow, 1999</xref>; <xref ref-type="bibr" rid="bib64">White, 2018</xref>; <xref ref-type="bibr" rid="bib36">Njuguna et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). For our study, 552 of the admissions were pragmatically selected to ensure adequate sampling of the transmission periods and clinical phenotypes (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). 150 patients presented with moderate malaria and 402 with one or a combination of the severe malaria syndromes: impaired consciousness (IC), respiratory distress (RD), and severe malaria anemia (SMA) (<xref ref-type="bibr" rid="bib32">Marsh et al., 1995</xref>; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). 223 samples from children presenting with mild malaria at outpatient clinics and 53 asymptomatic children from a longitudinal malaria cohort study were added to cover the full range of the possible outcomes of malaria infection (<xref ref-type="fig" rid="fig1">Figure 1B–E</xref>), bringing the total number included in this study to 828 children. The characteristics of participants and clinical parameters are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>A clinical malaria patient cohort during changing the transmission in Kilifi, Kenya.</title><p>(<bold>A</bold>) Total malaria admissions and patient age of the parent cohort. Number of patients per year (gray histogram, left axis). The solid blue line is the average patient age in the parent cohort, the dashed line is the average patient age in this study (both right axis). (<bold>B</bold>) Schematic of sample selection for this study. (<bold>C</bold>) Clinical presentation of patients selected for this study. Left: all patients, middle: admissions only, right: subset selected for luminex and lipidomics analysis. sma = severe malarial anemia, ic = impaired consiousness, rd = respiratory distress. (<bold>D</bold>) Number of patients in this study with different clinical presentations (402 severe cases initially selected). (<bold>E</bold>) Overview of the data available for each patient of the study, after excluding samples with <italic>Pfsir2a</italic> and <italic>ap2-g</italic> transcript transcription units greater or equal to 32 as described in the methods. Each row is one patient, organized by patient category (left axis) and transmission period (right axis).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>Dynamics of parasite parameters across transmission period and clinical phenotype</title><p>First, we analyzed the dynamics of parasite parameters across transmission periods and clinical outcomes. For this purpose, we measured both total parasite biomass based on <italic>Pf</italic>HRP2 levels (<xref ref-type="bibr" rid="bib17">Dondorp et al., 2005</xref>) and peripheral parasitemia based on parasite counts from blood smears. Total parasite biomass (<italic>Pf</italic>HRP2) but not peripheral parasitemia decreased with declining transmission (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This decrease was significant in the patients presenting with mild malaria at outpatient clinics which is a more homogenous clinical subgroup as compared to admissions consisting of a range of clinical phenotypes (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Dynamics of parasite parameters across transmission periods.</title><p>(<bold>A</bold>) Peripheral parasitemia (smear, left), total parasite biomass (<italic>Pf</italic>HRP2, middle), and patient age (right) across patients. Number of patients: Asymptomatics: decline: n=29, postdecline: n=21; Outpatients: predecline: n=35, decline: n=94, postdecline: n=70; Admissions: predecline: n=185, decline: n=175, postdecline: n=164. (<bold>B</bold>) <italic>ap2-g</italic> transcript levels (left) and <italic>Pfsir2a</italic> levels (right) across patients. (<bold>C</bold>) Spearman’s correlation between <italic>Pfs16</italic> and <italic>ap2-g</italic> (blue), or <italic>PfSir2a</italic> transcription (red) across patients (corrected for transmission). The lines fitted are linear regressions for visualization only. (<bold>D</bold>) Spearman’s correlation between <italic>Pfsir2a</italic> and <italic>ap2-g</italic> transcription (blue), or <italic>Pf</italic>HRP2 levels (red) across patients (corrected for transmission). The lines fitted are linear regressions for visualization only. (<bold>E</bold>) <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription (corrected for transmission) stratified by patient temperature. &quot;&lt;37.5&quot;: n=122, &quot;&gt;=37.5 &amp; &lt;39&quot;: n=228, &quot;&gt;=39&quot;: n=196. (<bold>F</bold>) Linear regression showing the association of <italic>var</italic> gene transcription levels with <italic>Pfsir2a</italic> levels (adjusted for transmission). 95% confidence intervals are shown. n=723 for all but c2 n=577. The color indicates whether the relationship is statistically significant (with Benjamini &amp; Hochberg multiple tests correction). Positive correlations are in red, and negative in blue. gpA1, gpA2, and dc13 represent group A <italic>var</italic> gene transcripts. dc8-1 to dc8-4 represent DC8 <italic>var</italic> gene transcripts while gpb1 and gpc2 represent group B and C <italic>var</italic> genes. In the above graphs C-F (and all subsequent figures), asymptomatics were excluded in analyses involving the transmission period since they are not represented in the pre-decline period. All pairwise statistical tests indicated in the graphs are Wilcoxon tests corrected for multiple testing (Benjamini &amp; Hochberg, *=FDR &lt; 0.05, **=&lt;0.01, ***=&lt;0.001, and ****=&lt;0.0001).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Parasite parameters stratified by clinical categories.</title><p><italic>ap2-g</italic>, <italic>Pfsir2a</italic>, <italic>var</italic> gene transcription, and <italic>Pf</italic>HRP2 levels stratified by clinical categories. Significant Wilcoxon test <italic>p</italic>-values (corrected for multiple testing) marked with *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. Number of patients: A,B,D,E: asymptomatics: n=50, outpatients: n=199, moderate: n=147, sma=100, ic=286, rd=115; C: asymptomatics n=38, outpatients: n=174, moderate: n=126, sma=95, ic=260, rd=100; F: asymptomatics: n=29, outpatients: n=175, moderate: n=101, sma: n=92, ic: n=215, rd: n=85.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Parasite samples were subjected to qRT-PCR analysis to quantify transcription of <italic>ap2-g</italic>, <italic>Pfsir2a,</italic> and <italic>var</italic> gene subgroups relative to two housekeeping genes (fructose biphosphate aldolase and seryl tRNA synthetase) (<xref ref-type="bibr" rid="bib47">Salanti et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">Rottmann et al., 2006</xref>; <xref ref-type="bibr" rid="bib28">Lavstsen et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>). In line with recent findings (<xref ref-type="bibr" rid="bib44">Rono et al., 2018</xref>), <italic>ap2-g</italic> transcription increased significantly with declining malaria transmission (<xref ref-type="fig" rid="fig2">Figure 2B</xref><bold>, left</bold>). In the subsequent analysis, only clinical cases were considered. Asymptomatic patients were excluded except for analysis of clinical phenotype since asymptomatic sampling was limited to the decline and post-decline periods (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), and, therefore, data could not be corrected for transmission.</p><p>Further analysis demonstrated that <italic>ap2-g</italic> transcription is highly significantly correlated with transcription levels of the gametocyte marker <italic>Pfs16</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This association validates <italic>ap2-g</italic> as a proxy for both, stage conversion and gametocyte levels. <italic>Pfsir2a</italic> transcription followed the same trend across transmission periods (<xref ref-type="fig" rid="fig2">Figure 2B</xref><bold>, right</bold>) and was positively associated with <italic>ap2-g</italic> transcription (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). <italic>Pfsir2a</italic> and <italic>ap2-g</italic> transcription also showed a positive association with fever (<xref ref-type="fig" rid="fig2">Figure 2E</xref>)<bold>,</bold> suggesting that both factors are sensitive to changes in the host inflammatory response. <italic>Pfsir2a</italic> but not <italic>ap2-g</italic> transcription also showed a significant negative association with <italic>Pf</italic>HRP2 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Given this unexpected observation, we investigated the well-established associations between <italic>Pfsir2a</italic> transcription and <italic>var</italic> gene transcription patterns (<xref ref-type="bibr" rid="bib34">Merrick et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>). <italic>Pfsir2a</italic> transcription showed a positive association with global upregulation of <italic>var</italic> gene transcription, particularly with subgroup B (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Likewise, transcription of group B <italic>var</italic> subgroup, <italic>Pfsir2a,</italic> and <italic>ap2-g</italic> transcription followed a similar pattern in relation to clinical phenotypes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). To ensure that there is no systematic bias in the qRT-PCR data, we also tested the association of <italic>Pfs16</italic> expression against <italic>var</italic> gene subgroups. <italic>Pfs16</italic> expression showed a significant positive correlation with group B (here termed gpb1) and C (gpc2) <italic>var</italic> genes, while no correlation was observed with the rest of the <italic>var</italic> subgroups (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Altogether these data suggest co-regulation of <italic>ap2-g</italic> and <italic>Pfsir2a</italic> and a negative association between <italic>Pfsir2a</italic> and <italic>Pf</italic>HRP2, likely through host factors that are changing with the declining transmission.</p></sec><sec id="s2-3"><title><italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription is associated with a distinct host inflammation profile</title><p>We hypothesized that the observed variation in <italic>ap2-g</italic> and <italic>Pfsir2a</italic> levels across the transmission period and clinical phenotype is due to underlying differences in the host inflammatory response. To test this hypothesis, we quantified 34 inflammatory markers (<xref ref-type="bibr" rid="bib23">Huang et al., 2017</xref>) with Luminex xMAP technology in the plasma of the 523 patients from the outpatient and admissions groups (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These patients were selected from the original set of 828 to ensure adequate representation of the transmission periods and clinical phenotypes (including fever), as summarized in <xref ref-type="fig" rid="fig1">Figure 1C and E</xref>. For this analysis, all associations were corrected for patient age and <italic>Pf</italic>HRP2 levels as possible confounders.</p><p>The markers MCP-1, IL-10, IL-6, and IL-1ra were significantly positively correlated with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). To cluster the inflammatory markers based on their correlation within the dataset, we used exploratory factor analysis and retained five factors with eigenvalues above 1 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Factor loadings structured the inflammation markers into five profiles with distinct inflammatory states (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). F1 consists of a mixture of inflammatory markers that support effector Th1/Th2/Th9/Th17 responses (i.e. hyperinflammatory state), F2 represents a Th2 response, F3 represents markers that support follicular helper T cell development and Th17 (<xref ref-type="bibr" rid="bib18">Dong, 2021</xref>; <xref ref-type="bibr" rid="bib11">Chao et al., 2023</xref>), F4 represents markers of immune paralysis/tissue-injury linked to response to cellular/tissue injury (<xref ref-type="bibr" rid="bib26">Kumar et al., 2014</xref>), and F5 represents the inflammasome/Th1 response (<xref ref-type="bibr" rid="bib63">Weiss et al., 2018</xref>). F4 showed a significant positive association with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription and fever (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In contrast, F5 showed a negative association with <italic>ap2-g</italic> and fever while F1 was positively associated with fever (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In parallel with the observed decrease in <italic>Pf</italic>HRP2 levels (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), F1 and F5 significantly declined with falling transmission (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription levels are associated with the host inflammation profile.</title><p>(<bold>A</bold>) Association of inflammatory markers with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcripts, tested using transmission period, age, and <italic>Pf</italic>HRP2 adjusted linear regression (<italic>p-</italic>values adjusted for multiple testing using Benjamini &amp; Hochberg multiple tests correction). Plotted is the regression coefficient (estimate) and 95% CI. Above and below zero indicate statistically significant positive (red) and negative associations (blue), respectively. n=523 (<bold>B</bold>) Principal exploratory factor analysis. The figure shows the inflammatory marker loadings on the five factors (<bold>F1–F5</bold>) identified to have eigenvalue above 1. (<bold>C</bold>) Linear regression between inflammatory factors. (<bold>F1–F5</bold>) and <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription and patient temperature (adjusted for transmission, <italic>Pf</italic>HRP2, and age). Plotted is the coefficient between the factor and the parameter (estimate) and 95% CI. Number of Patients: <italic>ap2-g</italic> and <italic>Pfsir2a</italic>: n=523, Temperature: n=496. The association is significant if the correlation FDR &lt;0.05, in which case the positive associations are marked in red and the negative ones in blue. (<bold>D</bold>) Inflammatory factors stratified by transmission period. Pairwise tests are Wilcoxon tests (Benjamini &amp; Hochberg, *=FDR &lt; 0.05, **=&lt;0.01, ***=&lt;0.001, and ****=&lt;0.0001). Number of patients: predecline: n=131, decline: n=180, postdecline: n=212.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Parasite and inflammatory markers stratified by transmission period.</title><p>(<bold>A</bold>) Linear regression between <italic>ap2-g</italic> (left), <italic>Pfs16</italic> (middle), or <italic>Pfsir2a</italic> (right) transcript levels and <italic>ap2-g</italic>, <italic>Pfs16</italic>, Pfsir2a, <italic>var</italic> gene transcripts levels as per <xref ref-type="fig" rid="fig3">Figure 3A</xref>. Data are corrected for transmission period, age, and <italic>Plasmodium falciparum</italic> histidine-rich protein 2 (<italic>Pf</italic>HRP2). Number of patients: see <xref ref-type="fig" rid="fig2">Figure 2F</xref> (<bold>B</bold>) Linear regressions between <italic>ap2-g</italic> (<bold>left</bold>) <italic>or Pfsir2a</italic> (<bold>right</bold>) transcript levels and luminex markers as per <xref ref-type="fig" rid="fig3">Figure 3A</xref>, stratified by transmission period. Number of patients: predecline: n=131, decline: n=180, postdecline: n=212.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Factor loadings.</title><p>(<bold>A</bold>) Scree plot showing the eigenvalues vs the number of factors (factor analysis of the luminex data). (<bold>B</bold>) Major loadings of each factor calculated by factor analysis of the luminex data (values ≥ 0.3). Loading values are noted on the edges.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Correcting <italic>Plasmodium falciparum</italic> histidine-rich protein 2 (<italic>Pf</italic>HRP2) vs <italic>Pfsir2a</italic> associations for external factors.</title><p>Plotted is the linear regression coefficient (estimate) and 95% CI. Blue indicates a significant negative correlation between <italic>Pf</italic>HRP2 levels and <italic>Pfsir2a</italic> transcription with the additional correction indicated on the left. Number of patients: all cytokines: n=517, age: n=632, hb_plus: n=599, parasit (parasitemia): n=643, ntemp_plus(patient temperature): n=497.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig3-figsupp3-v2.tif"/></fig></fig-group><p>The data support our hypothesis and suggest that the host inflammatory response changes with the falling transmission. Of note, the observed negative association between <italic>Pfsir2a</italic> transcription and <italic>Pf</italic>HRP2 levels appears to be independent of the measured cytokine levels (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>) and is hence likely the result of parasite intrinsic regulation of replication.</p></sec><sec id="s2-4"><title>Plasma phospholipids link variation in the host inflammatory profile to <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription</title><p>We have previously demonstrated in vitro that the serum phospholipid LPC serves as a substrate for parasite membrane biosynthesis during asexual replication, and as an environmental factor sensed by the parasite that triggers stage conversion (<xref ref-type="bibr" rid="bib7">Brancucci et al., 2017</xref>). Plasma LPC is mainly derived from the turnover of phosphatidylcholine (PC) via phospholipase A2, while in the presence of Acyl-CoA the enzyme LPC acyltransferase (LPCAT) can drive the reaction in the other direction (<xref ref-type="bibr" rid="bib29">Law et al., 2019</xref>; <xref ref-type="bibr" rid="bib4">Amunugama et al., 2021</xref>). LPC is an inflammatory mediator that boosts type 1 immune response to eliminate pathogens (<xref ref-type="bibr" rid="bib22">Huang et al., 1999</xref>; <xref ref-type="bibr" rid="bib40">Qin et al., 2014</xref>). LPC turnover to PC can be triggered by inflammatory responses aimed to repair and restore tissue homeostasis rather than eliminate infection (<xref ref-type="bibr" rid="bib29">Law et al., 2019</xref>). Here, we performed an unbiased lipidomics analysis of plasma from a representative subset of the outpatient and admission patients (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) to explore whether the host inflammatory profile modifies the plasma lipid profile and consequently <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription levels in vivo.</p><p>We examined associations between the host inflammatory factors (F1-F5) and the plasma lipidome data. Again, these associations were corrected for transmission period, patient age, and <italic>Pf</italic>HRP2 levels. 24 lipid species dominated by phospholipids, showed significant association with the inflammatory factors at a false discovery rate below 0.05 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Like the observed associations with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription, cytokines in the F4 and F5 factors showed reciprocal associations with various LPC species and PC (<xref ref-type="fig" rid="fig4">Figure 4A</xref>): F5 showed a significant positive association with one LPC species and negative associations with PC, respectively, while F4 showed a significant negative association with three LPC species (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The positive association of LPC with the F5 inflammatory factor is consistent with previous findings that identified LPC as an immunomodulator that can enhance IFN-γ production and the activation of the inflammasome (<xref ref-type="bibr" rid="bib22">Huang et al., 1999</xref>; <xref ref-type="bibr" rid="bib40">Qin et al., 2014</xref>), which results in increased levels of cytokines such as IL-18 (<xref ref-type="bibr" rid="bib63">Weiss et al., 2018</xref>) and is necessary for eliminating parasites. Depletion of LPC is also associated with elevated markers of tissue injury (F4), perhaps following uncontrolled parasite growth or maladaptive inflammation. In summary, the association of inflammatory factors with lipids identified LPC, PC, and PE species as the most significant ones (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), in line with their known immunomodulatory role. Importantly, we observed the same pattern in a controlled human infection model where parasite densities were allowed to rise to microscopic levels, both after sporozoite, and blood-stage infection (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="bibr" rid="bib2">Alkema et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Alkema et al., 2022</xref>). Next, we examined the main lipid species associated with the five inflammatory factors with respect to <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription. Indeed, LPC species showed a negative association with both <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription levels (<xref ref-type="fig" rid="fig4">Figure 4C–F</xref>). The association was only significant in our data when inflammation is highest (and LPC level lowest), which is at low transmission (i.e. post decline). In contrast, LPC levels are highest and vary little across patients at high transmission (pre-decline).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Plasma Lysophosphatidylcholine (LPC) links host inflammation to <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription.</title><p>(<bold>A</bold>) Heatmap of the linear regression coefficients between lipids and inflammatory factors (F1-F5, adjusted for transmission period and corrected for multiple testing). Shown are all lipids that are significantly associated (positive or negative) with factors F1-F5, clustered using R hclust (distance = Euclidean, method = centroid) and that have been manually identified and filtered for peak quality (isotopes and fragments weres also filtered out). (<bold>B</bold>) Shown are the lipids with significant differences (student’s t-test corrected for multiple testing) between pre- and post-treatment in the controlled human malaria infections (CHMI) for either infection route (blood or sporozoite infection). Plotted is the fold-change post-treatment vs pre-treatment. On the left is indicated whether the lipid is significantly increased (red) or decreased (blue) in either route of infection. (<bold>C</bold>) Linear regression between the lipids from A and <italic>ap2-g</italic> or <italic>Pfsir2a</italic> transcription levels. Plotted is the coefficient and 95% CI. Blue indicates statistically significant negative correlations, while red indicates statically significant positive correlations (FDR &lt;0.05). (<bold>D</bold>) Distribution of <italic>ap2-g</italic> transcript levels (left) and LysoPC (16:0) intensity (right) across patients and stratified by transmission period. Data are corrected for age and <italic>Pf</italic>HRP2. (<bold>E</bold>) Correlation between LPC (16:0) (top) and <italic>ap2-g</italic> (top), or <italic>Pfsir2a</italic> (bottom) transcription (Spearman’s correlations corrected for multiple testing). (<bold>F</bold>) Correlations between identified LPCs and <italic>ap2-g</italic> transcription by transmission period (Spearman’s correlations corrected for multiple testing). Note that the predecline period is not plotted separately in panels C-E due to insufficient sample numbers for the statistical analysis. Number of patients: predecline: n=22, decline: n=53, postdecline: n=160.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Sample subsetting and batch correction for lipidomics data.</title><p>(<bold>A</bold>) Patient temperature, <italic>ap2-g</italic> transcription level, and disease type were used to subset samples for metabolomics. This resulted in five groups from severe disease categories and matching mild cases (outpatients, in gray). (<bold>B</bold>) PCA of the lipidomics data colored by batch number (post batch correction). (<bold>C</bold>) PCA of the lipidomics data colored by transmission period.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Controlled human malaria infections (CHMI) data.</title><p>(<bold>A</bold>) <italic>ap2-g</italic> transcription was measured on day 1 of treatment (<bold>T1</bold>) and stratified by type of infection. (<bold>B–E</bold>) Average (and standard deviation) cytokine levels during the experiment per infection type. Shown are those markers shared with the luminex analysis of the Kilifi cohort. (<bold>F</bold>) Average normalized lipid levels are significantly different pre and post-treatment (sp = sporozoite infection, bs = blood stage infection). (C=days post-infection, T=days post-treatment). On the left is indicated whether the lipid is significantly increased (red) or decreased (blue) in either type of infection. Number of patients: blood stage: n=11, sporozoite: n=6.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig4-figsupp2-v2.tif"/></fig></fig-group><p>Altogether, these data provide in vivo evidence for the previously observed link between LPC depletion and <italic>ap2-g</italic> activation and strongly suggest that LPC is both, a key immune modulator and a metabolite whose level is sensed by the parasite. Importantly, the key relationships described in <xref ref-type="fig" rid="fig2">Figures 2</xref>—<xref ref-type="fig" rid="fig4">4</xref> were independently significant in a structural equation model that examined how host immunity modifies the host-parasite interaction, the within-host environment, and parasite investment in transmission or replication (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Malaria parasites must adapt to changing environmental conditions across the life cycle in the mammalian and mosquito hosts. Similarly, changing conditions across seasons and transmission settings require both within- and between-host adaptation to optimize survival in the human host <italic>versus</italic> transmission to the next host. First, a recent transcriptomic study from Kenya and Sudan suggested that parasites in low transmission settings (where within-host competition is low) invest more in gametocyte production compared to high transmission settings (where within-host competition is high) (<xref ref-type="bibr" rid="bib44">Rono et al., 2018</xref>). Second, a longitudinal study from Senegal demonstrated that human-to-mosquito transmission efficiency (and gametocyte density) increases when parasite prevalence in the human population decreases, suggesting that parasites can adapt to changes in the environment (<xref ref-type="bibr" rid="bib13">Churcher et al., 2015</xref>). However, the within-host mechanisms driving parasite adaptation to the prevailing environment remain unclear.</p><p>Here, we analyzed parasite and host signatures in the plasma from a large malaria patient cohort over 18 years of declining malaria transmission in Kenya. This investigation allowed us to define some of the within-host environmental factors that change with transmission intensity and consequently influence the parasite’s decision to invest in reproduction <italic>versus</italic> replication. A major strength of our study is that observations are from a single site and are thus plausibly reflective of transmission-related changes in parasite investments, rather than differences between geographically distinct parasite populations. We show that high transmission is associated with a host immune response that promotes parasite killing without compromising the intrinsic replicative ability of the individual parasite. In contrast, low transmission is associated with a host immune response that increases within-host stressors (fever, nutrient depletion), which trigger higher parasite investment into transmission (see also the model in <xref ref-type="fig" rid="fig5">Figure 5</xref>). Importantly, the observed associations between the parasite parameters <italic>ap2-g</italic>, <italic>Pfsir2a,</italic> and host inflammation remain significant if corrected for transmission, but they are strongest at low transmission (i.e. post decline period) when inflammation and the risk of damaging the host are highest. We anticipate that the proposed model could be tested in controlled human malaria infections with malaria naïve and semi-immune participants as a proxy for low vs high transmission settings.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Proposed model on a within-host adaptation of the parasite to changing environments.</title><p>The model is based on the interaction between the different host and parasite parameters described in this study. It proposes that declining transmission reduces host immunity, resulting in an inflammatory response associated with increased host stressors (including reduced Lysophosphatidylcholine (LPC) availability, and fever) and susceptibility to clinical symptoms/damage. The altered host response modifies the parasite response during infection, resulting in increased investment in transmission (as indicated by the elevated <italic>ap2-g</italic> levels) and reduced replication (as indicated by elevated <italic>Pfsir2a</italic> levels and reduced parasite burden/<italic>Plasmodium falciparum</italic> histidine-rich protein 2 (<italic>Pf</italic>HRP2) levels).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85140-fig5-v2.tif"/></fig><p>At a systemic level, inflammation can influence the within-host environment and modulate parasite investment in replication <italic>versus</italic> reproduction by altering the levels of environmental stressors (e.g. oxidative, thermal, or nutritional stress). Consistent with this hypothesis, we show that a pro-inflammatory response mediated by IFN-γ/IL-18 (F5 in our analysis) promoting pathogen killing (<xref ref-type="bibr" rid="bib63">Weiss et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Hoffman et al., 1997</xref>; <xref ref-type="bibr" rid="bib25">Kearney et al., 2013</xref>) is negatively associated with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription. In contrast, inflammatory markers that increase within-host environmental stress (e.g. fever) or reflect the extent of host tissue injury and are secreted to heal and restore homeostasis rather than kill pathogens (F4) (<xref ref-type="bibr" rid="bib50">Shapouri-Moghaddam et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Tan et al., 2021</xref>) are positively associated with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription. At a metabolic level, we previously demonstrated that LPC depletion induces <italic>ap2-g</italic> transcription and, therefore, gametocyte production in vitro (<xref ref-type="bibr" rid="bib7">Brancucci et al., 2017</xref>). A recent study has provided the first indications of a possible association between LPC and <italic>ap2-g</italic> levels in a small malaria patient cohort (<xref ref-type="bibr" rid="bib61">Usui et al., 2019</xref>). Here, we reveal that LPC levels are negatively associated with <italic>ap2-g</italic> transcription in patient plasma, thus providing direct evidence for our in vitro findings (<xref ref-type="bibr" rid="bib7">Brancucci et al., 2017</xref>) across a large malaria patient cohort. LPC is an immune effector molecule promoting macrophage polarization to M1 phenotype that induces the secretion of various cytokines such as IFN-γ and IL-1 family (i.e. IL-18) (<xref ref-type="bibr" rid="bib22">Huang et al., 1999</xref>; <xref ref-type="bibr" rid="bib40">Qin et al., 2014</xref>) through activation of the inflammasome in endothelial cells and peripheral blood mononuclear cells (PBMCs). Furthermore, LPC is the main component of the oxidized form of LDL (oxLDL) that induces inflammasome-mediated trained immunity in human monocytes (<xref ref-type="bibr" rid="bib29">Law et al., 2019</xref>; <xref ref-type="bibr" rid="bib4">Amunugama et al., 2021</xref>), resulting in increased responsiveness to LPS re-stimulation. Indeed, we demonstrate that LPC levels are positively associated with IFN-γ/IL-18 levels (Factor 5). These observations are in line with recent data from experimentally infected macaques and malaria patients, where LPC levels decreased in the acute phase compared to the pre-challenge and the chronic phase (<xref ref-type="bibr" rid="bib15">Cordy et al., 2019</xref>). LPC is also a nutritional resource required by the parasite for replication (<xref ref-type="bibr" rid="bib7">Brancucci et al., 2017</xref>) and hence scarcity is expected to promote reproduction, as gametocytes require less nutritional resource and, therefore, provide a better adaptation strategy.</p><p>Surprisingly, we also identified a link between <italic>Pfsir2a</italic> transcription, host inflammatory response, and parasite biomass (<italic>Pf</italic>HRP2). <italic>Pf</italic>Sir2a belongs to the evolutionarily conserved family of sirtuins that act as environmental sensors to regulate various cellular processes (<xref ref-type="bibr" rid="bib30">Li, 2013</xref>; <xref ref-type="bibr" rid="bib62">Vasquez et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Palacios et al., 2009</xref>). In <italic>P. falciparum</italic>, PfSir2a and PfSir2b paralogues cooperate to regulate virulence gene transcription including <italic>var</italic> genes (<xref ref-type="bibr" rid="bib59">Tonkin et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">Duraisingh et al., 2005</xref>). In vitro data have also demonstrated that increased PfSir2a levels are associated with reduced parasite replication (i.e. lower merozoite numbers) (<xref ref-type="bibr" rid="bib31">Mancio-Silva et al., 2013</xref>). We hypothesize that the observed upregulation of <italic>Pfsir2a</italic> transcription in response to inflammation is part of an orchestrated stress response linking replication and antigenic variation (via <italic>Pfsir2a</italic>) to reproduction and transmission (via <italic>ap2-g</italic>), perhaps through a shared epigenetic control mechanism (<xref ref-type="bibr" rid="bib14">Coleman et al., 2014</xref>). It is well known that host tolerance to malaria infection reduces with falling transmission (<xref ref-type="bibr" rid="bib5">Borrmann et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">Dollat et al., 2019</xref>), as shown by the declining threshold of parasite biomass (<italic>Pf</italic>HRP2) required for clinical malaria. This suggests that parasites have more pronounced harmful consequences on the infected host (i.e. clinical symptoms) in low compared to high transmission settings, perhaps due to increasing host age (<xref ref-type="bibr" rid="bib55">Sorci et al., 2021</xref>). Under this scenario, we propose that parasites experience increased within-host stress to which they respond through increased <italic>ap2-g</italic> transcription (to increase reproduction, hence transmission) and increased <italic>Pfsir2a</italic> transcription (to affect stress coping mechanisms at the expense of replication, hence the negative association with <italic>Pf</italic>HRP2) – as part of a self-preservation strategy in the face of imminent risk of host death.</p><p>In summary, we propose a model where the falling host immunity with declining transmission modifies the predominant host immune response, and consequently, the within-host environment (e.g. LPC availability, fever), resulting in increased investment in transmission (i.e. higher <italic>ap2-g</italic> transcription) and limiting replication (i.e. higher <italic>Pfsir2a</italic> transcription). Our findings provide critical information to accurately model parasite population dynamics. They suggest that parasite populations in elimination scenarios may increase their transmission potential. Understanding how malaria parasites adapt to their environment, for example by increasing investment in transmission stages at low endemicity, is highly relevant for public health. Not only would this affect the timelines for successful elimination, but it would also form an important argument for the deployment of gametocytocidal drugs once transmission has been successfully reduced.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Study design and participants</title><p>Ethical approval was granted by the Scientific Ethics Review Unit of the Kenya Medical Research Institute under the protocol; KEMRI/SERU/3149, and informed consent was obtained from the parents/guardian of the children. The study was conducted in Kilifi county which is a malaria-endemic region along the Kenyan coast. Over the last three decades, Kilifi has experienced changes in the pattern of malaria transmission and clinical presentation spectrum (<xref ref-type="bibr" rid="bib38">O’Meara et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Mogeni et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Njuguna et al., 2019</xref>). The study included (i) children admitted with malaria at Kilifi county hospital (KCH) between 1994–2012 and recruited as part of the hospital admission surveillance system, (ii) children presenting with mild malaria at an outpatient clinic, and (iii) asymptomatic children which were part of a longitudinal malaria surveillance cohort which were sampled during annual cross-section bleed in 2007 and 2010. Clinical data, parasite isolates, and plasma samples collected from the children were used to conduct the study. The selection of sub-samples for quantifying inflammatory markers and lipids was informed by the availability of fever data and resources.</p></sec><sec id="s4-2"><title>Clinical definitions</title><p>Admission to malaria was defined as all hospitalized children with malaria parasitemia. The severe malaria syndromes: severe malarial anemia (SMA), impaired consciousness (IC), and respiratory distress (RD) were defined as hemoglobin &lt;5 g/dl, Blantyre coma score (BCS) &lt;5, and deep breathing, respectively (<xref ref-type="bibr" rid="bib32">Marsh et al., 1995</xref>). Malaria admissions that did not present with either of the severe malaria syndromes were defined as moderate malaria. Mild malaria was defined as stable children presenting at the outpatient clinic with peripheral parasitemia, and asymptomatic as those with positive malaria (Giemsa smear) but without fever or any other sign(s) of illness. The combination of mild and moderate was referred to as uncomplicated.</p></sec><sec id="s4-3"><title>Controlled infection cohort</title><p>Malaria naïve volunteers were infected by either bite from five <italic>P. falciparum</italic> 3D7–infected mosquitoes (n=12) or by intravenous injection with approximately 2800 <italic>P. falciparum</italic> 3D7–infected erythrocytes (n=12); treatment with piperaquine was provided at a parasite density of 5000 /mL or on day eight following blood-stage exposure, respectively (<xref ref-type="bibr" rid="bib3">Alkema et al., 2022</xref>).</p></sec><sec id="s4-4"><title>Parasite parameters</title><p>Thick and thin blood films were stained with Giemsa and examined for <italic>P. falciparum</italic> parasites according to standard methods. Data were presented as the number of infected RBCs per 500, 200, or 100 RBCs counted. This data was then used to calculate parasitemia per µl of blood using the formula described in ‘<ext-link ext-link-type="uri" xlink:href="https://iris.wpro.who.int/bitstream/handle/10665.1/14214/MM-SOP-09-eng.pdf">2096-OMS-GMP-SOP-09</ext-link><ext-link ext-link-type="uri" xlink:href="https://iris.wpro.who.int/bitstream/handle/10665.1/14214/MM-SOP-09-eng.pdf">–</ext-link><ext-link ext-link-type="uri" xlink:href="https://iris.wpro.who.int/bitstream/handle/10665.1/14214/MM-SOP-09-eng.pdf">20160222</ext-link><ext-link ext-link-type="uri" xlink:href="https://iris.wpro.who.int/bitstream/handle/10665.1/14214/MM-SOP-09-eng.pdf">_v2.indd (who.int)</ext-link>.’ Briefly, parasites/µl=number of parasitized RBCs × number of RBCs per µl /number of RBCs counted or the number of parasites counted × number of WBCs per µl/number of WBCs counted. Where data on the actual number of RBCs or number of WBCs per µl of blood was not available, 5 million RBCs and 8000 WBCs per µl of blood were assumed.</p></sec><sec id="s4-5"><title>PfHRP2 ELISA</title><p><italic>P. falciparum</italic> histidine-rich protein 2 (<italic>Pf</italic>HRP2) was quantified in the malaria acute plasma samples using ELISA as outlined. Nunc MaxiSorp flat-bottom 96-well plates (ThermoFisher Scientific) were coated with 100 µl/well of the primary/capture antibody [Mouse anti-<italic>Pf</italic>HRP2 monoclonal antibody (MPFM-55A; MyBioscience)] in 1 × phosphate buffered saline (PBS) at a titrated final concentration of 0.9 µg/ml (stock = 8.53 mg/ml; dilution = 1:10,000) and incubated overnight at 4 °C. On the following day, the plates were washed thrice with 1 × PBS/0.05% Tween-20 (Sigma-Aldrich) using a BioTek ELx405 Select washer (BioTek Instruments, USA) and blotted on absorbent paper to remove residual buffer. These plates were then blocked with 200 µl/well of 1 × PBS/3% Marvel skimmed milk (Premier Foods; Thame, Oxford) and incubated for 2 hr at room temperature (RT) on a shaker at 500 rpm. The plates were then washed thrice as before. After the final wash, plasma samples and standards were then added at 100 ul/well and in duplicates. The samples and standards (<italic>Pf</italic>HRP2 Recombinant protein; MBS232321, MyBioscience) had been appropriately diluted in 1 × PBS/2% bovine serum albumin (BSA). The samples and standards were incubated for 2 hr at RT on a shaker at 500 rpm followed by three washes with 1 × PBS/0.05% Tween-20 and blotted dry as before. This was followed by the addition of a 100 µl/well of the secondary/detection antibody [Mouse anti-<italic>Pf</italic>HRP2 HRP-conjugated antibody (MPFG-55P; MyBioscience) diluted in 1 × PBS/2% BSA and at a final titrated concentration of 0.2 µg/ml (stock = 1 mg/ml; dilution = 1:5000)]. The plates were then incubated for 1 hr at RT on a shaker at 500 rpm, washed thrice as before, and dried on absorbent paper towels. o-Phenylenediamine dihydrochloride (OPD) (ThermoFisher Scientific) substrate was then added at 100 µl/well and incubated for 15 min for color development. The reaction was stopped with 50 µl/well of 2 M sulphuric acid (H<sub>2</sub>SO<sub>4</sub>) and optical densities (OD) read at 490 nm with a BioTek Synergy4 reader (BioTek Instruments, USA).</p></sec><sec id="s4-6"><title>Parasite transcript quantification using quantitative RT-PCR</title><p>RNA was obtained from TRIzol reagent (Invitrogen, catalog number 15596026) preserved <italic>P. falciparum</italic> positive venous blood samples obtained from the children recruited in the study. RNA was extracted by Chloroform method (<xref ref-type="bibr" rid="bib9">Bull et al., 2005</xref>) and cDNA was synthesized using a Superscript III kit (Invitrogen, catalog number 18091050) following the manufacturer’s protocol. Parasite gene transcription analysis was carried out through quantitative real-time PCR as described below.</p><p>Real-time PCR data was obtained as described (<xref ref-type="bibr" rid="bib17">Dondorp et al., 2005</xref>; <xref ref-type="bibr" rid="bib5">Borrmann et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">Dollat et al., 2019</xref>). Four primer pairs targeting DC8 (named dc8-1, dc8-2, dc8-3, dc8-4), one primer pair targeting DC13 (dc13), and two primer pairs targeting the majority of group A <italic>var</italic> genes (gpA1 and gpA2) were used in real-time PCR analysis as described (<xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>). We also used two primer pairs, b1, and c2, targeting group B and C <italic>var</italic> genes, respectively (<xref ref-type="bibr" rid="bib45">Rottmann et al., 2006</xref>). Primer pairs targeting <italic>Pfsir2a,</italic> and <italic>ap2-g</italic> were also used (<xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>). Two housekeeping genes, Seryl tRNA synthetase and Fructose bisphosphate aldolase (<xref ref-type="bibr" rid="bib47">Salanti et al., 2003</xref>; <xref ref-type="bibr" rid="bib28">Lavstsen et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>) were used for relative quantification of the expressed <italic>var</italic> genes, <italic>Pfsir2a,</italic> and <italic>ap2-g</italic>. The PCR reaction and cycling conditions were carried out as described (<xref ref-type="bibr" rid="bib28">Lavstsen et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Abdi et al., 2016</xref>) using the Applied Biosystems 7500 Real-time PCR system. We set the cycle threshold (Ct) at 0.025. Controls with no template were included at the end of each batch of 22 samples per primer pair and the melt curves were analyzed for non-specific amplification. The <italic>var</italic> gene ‘transcript quantity’ was determined relative to the mean transcript of the two housekeeping genes, Sery tRNA synthetase and Fructose biphosphate aldolase as described (<xref ref-type="bibr" rid="bib28">Lavstsen et al., 2012</xref>). For each test primer, the ∆Ct was calculated relative to the average Ct of the two housekeeping genes which were then transformed to arbitrary transcript unit (Tu<sub>s</sub>) using the formula (Tu<sub>s</sub> = 2<sup>(5-∆ct)</sup>) as described (<xref ref-type="bibr" rid="bib28">Lavstsen et al., 2012</xref>). We assigned a zero Tu<sub>s</sub> value if a reaction did not result in detectable amplification after 40 cycles of amplification, that is, if the Ct value was undetermined.</p></sec><sec id="s4-7"><title>Measurement of cytokine levels in the plasma samples</title><p>The selection for this subset was primarily informed by the availability of fever data but the transmission period and clinical phenotype were also considered. However, there were more children with a fever data recorded in the post-decline period than in pre-decline and decline periods which biased the sampling toward the post-decline period. The plasma samples were analyzed using ProcartaPlex Human Cytokine &amp; Chemokine Panel 1 A(34plex) [Invitrogen/ThermoFisher Scientific; catalog # EPX340-12167-901; Lot:188561049] following the manufacturer’s instructions. The following 34 cytokines were measured: GM-CSF, IFN-α, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-18, IL-21, IL-22, IL-23, IL-27, IL-31, IP-10 (CXCL10), MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β (CCL4), TNF-α, TNF-β, Eotaxin/CCL11, RANTES, GRO-a, and SDF-1a.</p><p>Briefly, 50 µl of magnetic beads mix was added into each plate well and the 96-well plate was securely placed on a hand-held magnetic plate washer for 2 min for the beads to settle. The liquid was then removed by carefully inverting the plate over a waste container while still on the magnet and lightly blotted on absorbent paper towels. The beads were then washed by adding 150 µl of 1 × wash buffer, left to settle for 2 min, and the liquid removed as before followed by blotting. This was followed by adding 25 µl of Universal Assay Buffer per well and then 25 µl of plasma samples and standards into appropriate wells or 25 µl of Universal Assay Buffer in blank wells. The plate was covered and shaken on a plate shaker at 500 rpm for 30 min at room temperature followed by an overnight incubation at 4 °C. After the overnight incubation, the plate was shaken on a plate shaker at 500 rpm for 30 min at room temperature and the beads were then washed twice while on a magnetic plate holder as outlined above. The beads were then incubated in the dark with 25 µl of detection antibody mixture on a plate shaker at 500 rpm for 30 min at room temperature followed by two washes as before. A 50 µl of Streptavidin-Phycoerythrin (SAPE) solution was then added per well and similarly incubated for 30 min on a plate shaker at 500 rpm and at room temperature followed by two washes. After the final wash, the beads were resuspended in 120 µl of Reading Buffer per well, and incubated for 5 min on a plate shaker at 500 rpm before running on a MAGPIX reader running on MAGPIX xPOTENT 4.2 software (Luminex Corporation). The instrument was set to count 100 beads for each analyte. The analyte concentrations were calculated (via Milliplex Analyst v5.1 [VigeneTech]) from the median fluorescence intensity (MdFI) expressed in pg/mL using the standard curves of each cytokine.</p></sec><sec id="s4-8"><title>Lipidomics analysis</title><p>Patient temperature, <italic>ap2-g</italic> transcription level, and disease type were used to subset samples for lipidomics. This resulted in five groups from severe disease categories and matching mild cases (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Plasma samples were preserved at –80 °C until extraction with the chloroform/methanol method. 25 µL of plasma was extracted with 1 mL of the extraction solvent chloroform/methanol/water (1:3:1 ratio), the tubes were rocked for 10 min at 4 °C and centrifuged for 3 min at 13,000 g. Supernatant was collected and stored at –80 °C in glass tubes until analysis.</p><p>Sample vials were placed in the autosampler tray in random order and kept at 5 °C. Separation was performed using a Dionex UltiMate 3000 RSLC system (Thermo Scientific, Hemel Hempstead) by injection of 10 μl sample onto a silica gel column (150 mm × 3 mm × 3 μm; HiChrom, Reading, UK) used in hydrophilic interaction chromatography (HILIC) mode held at 30°C (<xref ref-type="bibr" rid="bib67">Zheng et al., 2010</xref>). Two solvents were used: solvent A [20% isopropyl alcohol (IPA) in acetonitrile] and solvent B [20% IPA in ammonium formate (20 mM)]. Elution was achieved using the following gradient at 0.3 ml/min: 0–1 min 8% B, 5 min 9% B, 10 min 20% B, 16 min 25% B, 23 min 35% B, and 26–40 min 8% B. Detection of lipids were performed in a Thermo Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific Inc, Hemel Hempstead, UK) in polarity switching mode. The instrument was calibrated according to the manufacturer’s specifications to give an rms mass error &lt;1 ppm. The following electrospray ionization settings were used: source voltage, ±4.30 kV; capillary temp, 325 °C; sheath gas flow, 40 arbitrary units (AU); auxiliary gas flow, 5 AU; sweep gas flow, 1 AU. All LC-MS spectra were recorded in the range of 100–1200 at 120,000 resolutions (FWHM at m/z 500).</p></sec><sec id="s4-9"><title>Data preprocessing</title><p>The raw data were converted to mzML files using proteowizard (v 3.0.9706 (2016-5-12)). These files were then analyzed using R (v 4.2.1) libraries xcms (v 3.14.1) and mzmatch 2 (v 1.0–4) for peak picking, alignment, filtering, and annotations (<xref ref-type="bibr" rid="bib12">Chong and Xia, 2018</xref>; <xref ref-type="bibr" rid="bib48">Scheltema et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Smith et al., 2006</xref>). Batch correction was applied as in (<ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/2218-1989/10/6/241/htm">https://www.mdpi.com/2218-1989/10/6/241/htm</ext-link>), and the data was then checked using PCA calculated using the R function prcomp (see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Data was then range normalized and logged transformed using MetaboanalystR (v3.1.0). The CHMI lipidomics data was analyzed the same way but did not require batch correction as the samples were run in one batch.</p></sec><sec id="s4-10"><title>Statistical analysis</title><p>Data analysis was performed using R (v4.2.1) except for the structural equation modeling which was done in Mplus8. We normalized non-normally distributed variables by log transformation. <italic>qRT-PCR:</italic> Zeros in qRT-PCR values were replaced by 0.001 (the value before log transformation as the smallest measured value is about 0.0017). The median transcript units from qRT-PCR were calculated as follows: DC8 median from four primer pairs used (DC8-1, DC8-2, DC8-3, and DC8-4) and group A median from three primer pairs (gpA1, gpA2, and dc13). Samples for which <italic>ap2-g</italic> or <italic>pfsir2a</italic> arbitrary transcript unit was greater or equal to 32 (that is the transcript quantity of the reference genes based on the formula (Tu<sub>s</sub> = 2<sup>(5-∆ct)</sup>) <xref ref-type="bibr" rid="bib67">Zheng et al., 2010</xref>) were deemed unreliable and excluded from the analysis that went into generating <xref ref-type="fig" rid="fig2">Figures 2</xref>—<xref ref-type="fig" rid="fig4">4</xref>. Comparison between the two groups was done using a two-sided Wilcoxon test. All correlations were conducted using Spearman’s rank correlation coefficient test. All forest plots were done using linear regressions adjusted for transmission period, <italic>Pf</italic>HRP2, and age of the patient (see figure legends) using R function lm. All multiple test corrections were done using Benjamini &amp; Hochberg multiple tests (using R function p.adjust).</p><sec id="s4-10-1"><title>Principal factor analysis</title><p>A measurement model (i.e. factor analytic model) was fitted to summarize the 34 analytes into fewer variables called factors. An exploratory factor analysis (EFA) was performed to explore the factor structure underlying the 34 analytes. Factors were retained based on the Kaiser’s ‘eigenvalue rule’ of retaining eigenvalues larger than 1. In addition, we also considered the scree plot, parallel analysis, fit statistics, and interpretability of the model/factors. This analysis resulted in the cytokine data being reduced to five factors. This analysis was done using the R ‘psych’ library (v 2.1.9) available at <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=psych">https://CRAN.R-project.org/package=psych</ext-link>. The 34 analytes were individually linearly regressed to <italic>ap2-g</italic> or <italic>Pfsir2</italic> transcript levels with the transmission, <italic>Pf</italic>HRP2, and age correction (model: analyte ~transmission + <italic>Pf</italic>HRP2 +age). Then each factor was analyzed the same way.</p></sec><sec id="s4-10-2"><title>Lipidomics analysis</title><p>The preprocessed lipidomics data was tested using transmission period, <italic>Pf</italic>HRP2, and age-adjusted linear regression with any of the five factors. All m/z with a significant false discovery rate with any of the factors were then manually checked for peak quality and identified masses on mass and retention time (<xref ref-type="bibr" rid="bib43">Reis et al., 2013</xref>). The remaining identified lipids were then checked for the relationship with <italic>ap2-g</italic> and <italic>Pfsir2a</italic> transcription levels (linear regression adjusted for transmission period, HRP, and age, see methods above). The CHMI lipidomics data was analyzed the same way but the peaks retained were those significantly different pre and post-treatment in either type of infection (student’s t-tests corrected for multiple testing).</p></sec><sec id="s4-10-3"><title>Figures</title><p>All heatmaps were done using the R library pheatmap (v 1.0.12) available at <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pheatmap">https://CRAN.R-project.org/package=pheatmap</ext-link>, and all other plots using the R libraries ggplot2 (v 3.3.5) and ggpubr (v 0.4.0) available at <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=ggpubr">https://CRAN.R-project.org/package=ggpubr</ext-link>.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Supervision</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Formal analysis</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Writing - review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Ethical approval was granted by the Scientific Ethics Review Unit of the Kenya Medical Research Institute under the protocol; KEMRI/SERU/3149, and informed consent was obtained from the parents/guardian of the children.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Associations between parasite parameters <italic>ap2-g</italic>, <italic>Pfsir2-a</italic> and <italic>Pf</italic>HRP2, and clinical parameters.</title></caption><media xlink:href="elife-85140-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Associations between parasite parameters <italic>ap2-g</italic>, <italic>Pfsir2-a</italic> and <italic>Pf</italic>HRP2, host luminex markers, and lipidomics data.</title></caption><media xlink:href="elife-85140-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Structural equation model (SEM).</title><p>The model assumes that pre-existing host immunity affects the interaction between the host (i.e. altered within the host environment including inflammatory response. fever, nutritional resource availability) and parasite (i.e. altered investment in reproduction <italic>vs</italic> replication). Significant <italic>p</italic>-values are highlighted in bold and negative and positive estimates of associations are highlighted in blue and red, respectively.</p></caption><media xlink:href="elife-85140-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85140-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Raw data and script for all the analyses in this manuscript are available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/BXXVRY">https://doi.org/10.7910/DVN/BXXVRY</ext-link>. mzML mass spectrometry files are available at MetaboLights at <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/metabolights/editor/study/MTBLS5130">https://www.ebi.ac.uk/metabolights/editor/study/MTBLS5130</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>AI</given-names></name><name><surname>Achcar</surname><given-names>F</given-names></name><name><surname>Sollelis</surname><given-names>L</given-names></name><name><surname>Silva-Filho</surname><given-names>JL</given-names></name><name><surname>Mwikali</surname><given-names>K</given-names></name><name><surname>Muthui</surname><given-names>M</given-names></name><name><surname>Mwangi</surname><given-names>S</given-names></name><name><surname>Kimingi</surname><given-names>HW</given-names></name><name><surname>Orindi</surname><given-names>B</given-names></name><name><surname>Kivisi</surname><given-names>CA</given-names></name><name><surname>Alkema</surname><given-names>M</given-names></name><name><surname>Chandrasekar</surname><given-names>A</given-names></name><name><surname>Bull</surname><given-names>PC</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Modrzynska</surname><given-names>K</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name><name><surname>Marti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title><italic>Plasmodium falciparum</italic> adapts its investment into replicationversustransmission according to the host environment</data-title><source>EBI</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/metabolights/editor/study/MTBLS5130">MTBLS5130</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>AI</given-names></name><name><surname>Achcar</surname><given-names>F</given-names></name><name><surname>Sollelis</surname><given-names>L</given-names></name><name><surname>Silva-Filho</surname><given-names>JL</given-names></name><name><surname>Mwikali</surname><given-names>K</given-names></name><name><surname>Muthui</surname><given-names>M</given-names></name><name><surname>Mwangi</surname><given-names>S</given-names></name><name><surname>Kimingi</surname><given-names>HW</given-names></name><name><surname>Orindi</surname><given-names>B</given-names></name><name><surname>Kivisi</surname><given-names>CA</given-names></name><name><surname>Alkema</surname><given-names>M</given-names></name><name><surname>Chandrasekar</surname><given-names>A</given-names></name><name><surname>Bull</surname><given-names>PC</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Modrzynska</surname><given-names>K</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name><name><surname>Marti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Replication Data for: Plasmodium falciparum adapts investment into replication versus reproduction transmission according to host environment</data-title><source>Harvard Dataverse</source><pub-id pub-id-type="doi">10.7910/DVN/BXXVRY</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Wolfson Merit Royal Society Award (to M.M.), Wellcome Trust Investigator Award 110166 (to F.A., L.S., J.L.S.F., and M.M.), and Wellcome Trust Center Award 104111 (to F F.A., L.S., J.L.S.F., and M.M.), Glasgow-Radboud collaborative grant (to M.A., T.B. and M.M.), European Research Council (ERC) Consolidator Grant (to T.B., ERC-CoG 864180 QUANTUM), Wellcome Award 209289/Z/17/Z (to A.A.) and a core Wellcome award to KEMRI-Wellcome Trust (203077/Z/16/Z). This paper was published with the permission of the director of Kenya Medical Research Institute.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>AI</given-names></name><name><surname>Warimwe</surname><given-names>GM</given-names></name><name><surname>Muthui</surname><given-names>MK</given-names></name><name><surname>Kivisi</surname><given-names>CA</given-names></name><name><surname>Kiragu</surname><given-names>EW</given-names></name><name><surname>Fegan</surname><given-names>GW</given-names></name><name><surname>Bull</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Global selection of <italic>Plasmodium falciparum</italic> virulence antigen expression by host antibodies</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>19882</elocation-id><pub-id pub-id-type="doi">10.1038/srep19882</pub-id><pub-id pub-id-type="pmid">26804201</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkema</surname><given-names>M</given-names></name><name><surname>Reuling</surname><given-names>IJ</given-names></name><name><surname>de Jong</surname><given-names>GM</given-names></name><name><surname>Lanke</surname><given-names>K</given-names></name><name><surname>Coffeng</surname><given-names>LE</given-names></name><name><surname>van Gemert</surname><given-names>GJ</given-names></name><name><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Ivinson</surname><given-names>K</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>McCarthy</surname><given-names>JS</given-names></name><name><surname>Sauerwein</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>KA</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A randomized clinical trial to compare <italic>Plasmodium falciparum</italic> gametocytemia and infectivity after blood-stage or mosquito bite-induced controlled malaria infection</article-title><source>The Journal of Infectious Diseases</source><volume>224</volume><fpage>1257</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa157</pub-id><pub-id pub-id-type="pmid">32239171</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkema</surname><given-names>M</given-names></name><name><surname>Yap</surname><given-names>XZ</given-names></name><name><surname>de Jong</surname><given-names>GM</given-names></name><name><surname>Reuling</surname><given-names>IJ</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Collins</surname><given-names>KA</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name><name><surname>McCall</surname><given-names>MBB</given-names></name><name><surname>Sauerwein</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Controlled human malaria infections by mosquito bites induce more severe clinical symptoms than asexual blood-stage challenge infections</article-title><source>EBioMedicine</source><volume>77</volume><elocation-id>103919</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.103919</pub-id><pub-id pub-id-type="pmid">35278741</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amunugama</surname><given-names>K</given-names></name><name><surname>Pike</surname><given-names>DP</given-names></name><name><surname>Ford</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The lipid biology of sepsis</article-title><source>Journal of Lipid Research</source><volume>62</volume><elocation-id>100090</elocation-id><pub-id pub-id-type="doi">10.1016/j.jlr.2021.100090</pub-id><pub-id pub-id-type="pmid">34087197</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrmann</surname><given-names>S</given-names></name><name><surname>Sasi</surname><given-names>P</given-names></name><name><surname>Mwai</surname><given-names>L</given-names></name><name><surname>Bashraheil</surname><given-names>M</given-names></name><name><surname>Abdallah</surname><given-names>A</given-names></name><name><surname>Muriithi</surname><given-names>S</given-names></name><name><surname>Frühauf</surname><given-names>H</given-names></name><name><surname>Schaub</surname><given-names>B</given-names></name><name><surname>Pfeil</surname><given-names>J</given-names></name><name><surname>Peshu</surname><given-names>J</given-names></name><name><surname>Hanpithakpong</surname><given-names>W</given-names></name><name><surname>Rippert</surname><given-names>A</given-names></name><name><surname>Juma</surname><given-names>E</given-names></name><name><surname>Tsofa</surname><given-names>B</given-names></name><name><surname>Mosobo</surname><given-names>M</given-names></name><name><surname>Lowe</surname><given-names>B</given-names></name><name><surname>Osier</surname><given-names>F</given-names></name><name><surname>Fegan</surname><given-names>G</given-names></name><name><surname>Lindegårdh</surname><given-names>N</given-names></name><name><surname>Nzila</surname><given-names>A</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Mackinnon</surname><given-names>M</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Declining responsiveness of <italic>Plasmodium falciparum</italic> infections to artemisinin-based combination treatments on the kenyan coast</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e26005</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0026005</pub-id><pub-id pub-id-type="pmid">22102856</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch-Presegué</surname><given-names>L</given-names></name><name><surname>Vaquero</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sirtuins in stress response: guardians of the genome</article-title><source>Oncogene</source><volume>33</volume><fpage>3764</fpage><lpage>3775</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.344</pub-id><pub-id pub-id-type="pmid">23995787</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brancucci</surname><given-names>NMB</given-names></name><name><surname>Gerdt</surname><given-names>JP</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>De Niz</surname><given-names>M</given-names></name><name><surname>Philip</surname><given-names>N</given-names></name><name><surname>Adapa</surname><given-names>SR</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Hitz</surname><given-names>E</given-names></name><name><surname>Niederwieser</surname><given-names>I</given-names></name><name><surname>Boltryk</surname><given-names>SD</given-names></name><name><surname>Laffitte</surname><given-names>MC</given-names></name><name><surname>Clark</surname><given-names>MA</given-names></name><name><surname>Grüring</surname><given-names>C</given-names></name><name><surname>Ravel</surname><given-names>D</given-names></name><name><surname>Blancke Soares</surname><given-names>A</given-names></name><name><surname>Demas</surname><given-names>A</given-names></name><name><surname>Bopp</surname><given-names>S</given-names></name><name><surname>Rubio-Ruiz</surname><given-names>B</given-names></name><name><surname>Conejo-Garcia</surname><given-names>A</given-names></name><name><surname>Wirth</surname><given-names>DF</given-names></name><name><surname>Gendaszewska-Darmach</surname><given-names>E</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name><name><surname>Adams</surname><given-names>JH</given-names></name><name><surname>Voss</surname><given-names>TS</given-names></name><name><surname>Waters</surname><given-names>AP</given-names></name><name><surname>Jiang</surname><given-names>RHY</given-names></name><name><surname>Clardy</surname><given-names>J</given-names></name><name><surname>Marti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lysophosphatidylcholine regulates sexual stage differentiation in the human malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Cell</source><volume>171</volume><fpage>1532</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.020</pub-id><pub-id pub-id-type="pmid">29129376</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckling</surname><given-names>A</given-names></name><name><surname>Ranford-Cartwright</surname><given-names>LC</given-names></name><name><surname>Miles</surname><given-names>A</given-names></name><name><surname>Read</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Chloroquine increases <italic>Plasmodium falciparum</italic> gametocytogenesis in vitro</article-title><source>Parasitology</source><volume>118 (Pt 4)</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1017/s0031182099003960</pub-id><pub-id pub-id-type="pmid">10340323</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bull</surname><given-names>PC</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Kyes</surname><given-names>S</given-names></name><name><surname>Quail</surname><given-names>MA</given-names></name><name><surname>Hall</surname><given-names>N</given-names></name><name><surname>Kortok</surname><given-names>MM</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Newbold</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title><italic>Plasmodium falciparum</italic> variant surface antigen expression patterns during malaria</article-title><source>PLOS Pathogens</source><volume>1</volume><elocation-id>e26</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0010026</pub-id><pub-id pub-id-type="pmid">16304608</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Evidence for environmental modulation of gametocytogenesis in <italic>Plasmodium falciparum</italic> in continuous culture</article-title><source>Bulletin of the World Health Organization</source><volume>57 Suppl 1</volume><fpage>37</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">397008</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>YY</given-names></name><name><surname>Puhach</surname><given-names>A</given-names></name><name><surname>Frieser</surname><given-names>D</given-names></name><name><surname>Arunkumar</surname><given-names>M</given-names></name><name><surname>Lehner</surname><given-names>L</given-names></name><name><surname>Seeholzer</surname><given-names>T</given-names></name><name><surname>Garcia-Lopez</surname><given-names>A</given-names></name><name><surname>van der Wal</surname><given-names>M</given-names></name><name><surname>Fibi-Smetana</surname><given-names>S</given-names></name><name><surname>Dietschmann</surname><given-names>A</given-names></name><name><surname>Sommermann</surname><given-names>T</given-names></name><name><surname>Ćiković</surname><given-names>T</given-names></name><name><surname>Taher</surname><given-names>L</given-names></name><name><surname>Gresnigt</surname><given-names>MS</given-names></name><name><surname>Vastert</surname><given-names>SJ</given-names></name><name><surname>van Wijk</surname><given-names>F</given-names></name><name><surname>Panagiotou</surname><given-names>G</given-names></name><name><surname>Krappmann</surname><given-names>D</given-names></name><name><surname>Groß</surname><given-names>O</given-names></name><name><surname>Zielinski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Human th17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation</article-title><source>Nature Immunology</source><volume>24</volume><fpage>295</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/s41590-022-01386-w</pub-id><pub-id pub-id-type="pmid">36604548</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data</article-title><source>Bioinformatics</source><volume>34</volume><fpage>4313</fpage><lpage>4314</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty528</pub-id><pub-id pub-id-type="pmid">29955821</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churcher</surname><given-names>TS</given-names></name><name><surname>Trape</surname><given-names>JF</given-names></name><name><surname>Cohuet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human-to-mosquito transmission efficiency increases as malaria is controlled</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6054</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7054</pub-id><pub-id pub-id-type="pmid">25597498</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>BI</given-names></name><name><surname>Skillman</surname><given-names>KM</given-names></name><name><surname>Jiang</surname><given-names>RHY</given-names></name><name><surname>Childs</surname><given-names>LM</given-names></name><name><surname>Altenhofen</surname><given-names>LM</given-names></name><name><surname>Ganter</surname><given-names>M</given-names></name><name><surname>Leung</surname><given-names>Y</given-names></name><name><surname>Goldowitz</surname><given-names>I</given-names></name><name><surname>Kafsack</surname><given-names>BFC</given-names></name><name><surname>Marti</surname><given-names>M</given-names></name><name><surname>Llinás</surname><given-names>M</given-names></name><name><surname>Buckee</surname><given-names>CO</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A <italic>Plasmodium falciparum</italic> histone deacetylase regulates antigenic variation and gametocyte conversion</article-title><source>Cell Host &amp; Microbe</source><volume>16</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.06.014</pub-id><pub-id pub-id-type="pmid">25121747</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordy</surname><given-names>RJ</given-names></name><name><surname>Patrapuvich</surname><given-names>R</given-names></name><name><surname>Lili</surname><given-names>LN</given-names></name><name><surname>Cabrera-Mora</surname><given-names>M</given-names></name><name><surname>Chien</surname><given-names>JT</given-names></name><name><surname>Tharp</surname><given-names>GK</given-names></name><name><surname>Khadka</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>EV</given-names></name><name><surname>Lapp</surname><given-names>SA</given-names></name><name><surname>Joyner</surname><given-names>CJ</given-names></name><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Banton</surname><given-names>S</given-names></name><name><surname>Tran</surname><given-names>V</given-names></name><name><surname>Luvira</surname><given-names>V</given-names></name><name><surname>Rungin</surname><given-names>S</given-names></name><name><surname>Saeseu</surname><given-names>T</given-names></name><name><surname>Rachaphaew</surname><given-names>N</given-names></name><name><surname>Pakala</surname><given-names>SB</given-names></name><name><surname>DeBarry</surname><given-names>JD</given-names></name><name><surname>Kissinger</surname><given-names>JC</given-names></name><name><surname>Ortlund</surname><given-names>EA</given-names></name><name><surname>Bosinger</surname><given-names>SE</given-names></name><name><surname>Barnwell</surname><given-names>JW</given-names></name><name><surname>Jones</surname><given-names>DP</given-names></name><name><surname>Uppal</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Sattabongkot</surname><given-names>J</given-names></name><name><surname>Moreno</surname><given-names>A</given-names></name><name><surname>Galinski</surname><given-names>MR</given-names></name><collab>MaHPIC Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct amino acid and lipid perturbations characterize acute versus chronic malaria</article-title><source>JCI Insight</source><volume>4</volume><elocation-id>e125156</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.125156</pub-id><pub-id pub-id-type="pmid">31045574</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dollat</surname><given-names>M</given-names></name><name><surname>Talla</surname><given-names>C</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Diene Sarr</surname><given-names>F</given-names></name><name><surname>Trape</surname><given-names>JF</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Measuring malaria morbidity in an area of seasonal transmission: pyrogenic parasitemia thresholds based on a 20-year follow-up study</article-title><source>PLOS ONE</source><volume>14</volume><elocation-id>e0217903</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0217903</pub-id><pub-id pub-id-type="pmid">31246965</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondorp</surname><given-names>AM</given-names></name><name><surname>Desakorn</surname><given-names>V</given-names></name><name><surname>Pongtavornpinyo</surname><given-names>W</given-names></name><name><surname>Sahassananda</surname><given-names>D</given-names></name><name><surname>Silamut</surname><given-names>K</given-names></name><name><surname>Chotivanich</surname><given-names>K</given-names></name><name><surname>Newton</surname><given-names>PN</given-names></name><name><surname>Pitisuttithum</surname><given-names>P</given-names></name><name><surname>Smithyman</surname><given-names>AM</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Day</surname><given-names>NPJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Estimation of the total parasite biomass in acute falciparum malaria from plasma pfhrp2</article-title><source>PLOS Medicine</source><volume>2</volume><elocation-id>e204</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0020204</pub-id><pub-id pub-id-type="pmid">16104831</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cytokine regulation and function in T cells</article-title><source>Annual Review of Immunology</source><volume>39</volume><fpage>51</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-061020-053702</pub-id><pub-id pub-id-type="pmid">33428453</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duraisingh</surname><given-names>MT</given-names></name><name><surname>Voss</surname><given-names>TS</given-names></name><name><surname>Marty</surname><given-names>AJ</given-names></name><name><surname>Duffy</surname><given-names>MF</given-names></name><name><surname>Good</surname><given-names>RT</given-names></name><name><surname>Thompson</surname><given-names>JK</given-names></name><name><surname>Freitas-Junior</surname><given-names>LH</given-names></name><name><surname>Scherf</surname><given-names>A</given-names></name><name><surname>Crabb</surname><given-names>BS</given-names></name><name><surname>Cowman</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in <italic>Plasmodium falciparum</italic></article-title><source>Cell</source><volume>121</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.01.036</pub-id><pub-id pub-id-type="pmid">15820675</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>SWK</given-names></name><name><surname>Mahanta</surname><given-names>KC</given-names></name><name><surname>Pattnaik</surname><given-names>R</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><name><surname>Hasan</surname><given-names>MU</given-names></name><name><surname>Hossain</surname><given-names>A</given-names></name><name><surname>Charunwatthana</surname><given-names>P</given-names></name><name><surname>Chotivanich</surname><given-names>K</given-names></name><name><surname>Maude</surname><given-names>RJ</given-names></name><name><surname>Kingston</surname><given-names>H</given-names></name><name><surname>Day</surname><given-names>NP</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Dondorp</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria</article-title><source>The Journal of Infectious Diseases</source><volume>206</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis400</pub-id><pub-id pub-id-type="pmid">22693227</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>SL</given-names></name><name><surname>Crutcher</surname><given-names>JM</given-names></name><name><surname>Puri</surname><given-names>SK</given-names></name><name><surname>Ansari</surname><given-names>AA</given-names></name><name><surname>Villinger</surname><given-names>F</given-names></name><name><surname>Franke</surname><given-names>ED</given-names></name><name><surname>Singh</surname><given-names>PP</given-names></name><name><surname>Finkelman</surname><given-names>F</given-names></name><name><surname>Gately</surname><given-names>MK</given-names></name><name><surname>Dutta</surname><given-names>GP</given-names></name><name><surname>Sedegah</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Sterile protection of monkeys against malaria after administration of interleukin-12</article-title><source>Nature Medicine</source><volume>3</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/nm0197-80</pub-id><pub-id pub-id-type="pmid">8986746</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YH</given-names></name><name><surname>Schäfer-Elinder</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Claesson</surname><given-names>HE</given-names></name><name><surname>Frostegård</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism</article-title><source>Clinical and Experimental Immunology</source><volume>116</volume><fpage>326</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.1999.00871.x</pub-id><pub-id pub-id-type="pmid">10337026</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DTN</given-names></name><name><surname>Lu</surname><given-names>CY</given-names></name><name><surname>Chi</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>WL</given-names></name><name><surname>Chang</surname><given-names>LY</given-names></name><name><surname>Lai</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>JS</given-names></name><name><surname>Hsu</surname><given-names>WM</given-names></name><name><surname>Huang</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>11300</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-10749-5</pub-id><pub-id pub-id-type="pmid">28900138</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kafsack</surname><given-names>BFC</given-names></name><name><surname>Rovira-Graells</surname><given-names>N</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Bancells</surname><given-names>C</given-names></name><name><surname>Crowley</surname><given-names>VM</given-names></name><name><surname>Campino</surname><given-names>SG</given-names></name><name><surname>Williams</surname><given-names>AE</given-names></name><name><surname>Drought</surname><given-names>LG</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><name><surname>Baker</surname><given-names>DA</given-names></name><name><surname>Cortés</surname><given-names>A</given-names></name><name><surname>Llinás</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A transcriptional switch underlies commitment to sexual development in malaria parasites</article-title><source>Nature</source><volume>507</volume><fpage>248</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/nature12920</pub-id><pub-id pub-id-type="pmid">24572369</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>C</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections</article-title><source>Immunologic Research</source><volume>55</volume><fpage>187</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s12026-012-8362-y</pub-id><pub-id pub-id-type="pmid">22983898</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Voswinckel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>51</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2013-0382PS</pub-id><pub-id pub-id-type="pmid">25171460</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langhorne</surname><given-names>J</given-names></name><name><surname>Ndungu</surname><given-names>FM</given-names></name><name><surname>Sponaas</surname><given-names>AM</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Immunity to malaria: more questions than answers</article-title><source>Nature Immunology</source><volume>9</volume><fpage>725</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1038/ni.f.205</pub-id><pub-id pub-id-type="pmid">18563083</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Saguti</surname><given-names>F</given-names></name><name><surname>Magistrado</surname><given-names>P</given-names></name><name><surname>Rask</surname><given-names>TS</given-names></name><name><surname>Jespersen</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Berger</surname><given-names>SS</given-names></name><name><surname>Baraka</surname><given-names>V</given-names></name><name><surname>Marquard</surname><given-names>AM</given-names></name><name><surname>Seguin-Orlando</surname><given-names>A</given-names></name><name><surname>Willerslev</surname><given-names>E</given-names></name><name><surname>Gilbert</surname><given-names>MTP</given-names></name><name><surname>Lusingu</surname><given-names>J</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title><italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children</article-title><source>PNAS</source><volume>109</volume><fpage>E1791</fpage><lpage>E1800</lpage><pub-id pub-id-type="doi">10.1073/pnas.1120455109</pub-id><pub-id pub-id-type="pmid">22619319</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>SH</given-names></name><name><surname>Chan</surname><given-names>ML</given-names></name><name><surname>Marathe</surname><given-names>GK</given-names></name><name><surname>Parveen</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Ke</surname><given-names>LY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An updated review of lysophosphatidylcholine metabolism in human diseases</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>1149</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20051149</pub-id><pub-id pub-id-type="pmid">30845751</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sirt1 and energy metabolism</article-title><source>Acta Biochimica et Biophysica Sinica</source><volume>45</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/abbs/gms108</pub-id><pub-id pub-id-type="pmid">23257294</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancio-Silva</surname><given-names>L</given-names></name><name><surname>Lopez-Rubio</surname><given-names>JJ</given-names></name><name><surname>Claes</surname><given-names>A</given-names></name><name><surname>Scherf</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sir2a regulates rdna transcription and multiplication rate in the human malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Nature Communications</source><volume>4</volume><elocation-id>1530</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms2539</pub-id><pub-id pub-id-type="pmid">23443558</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Forster</surname><given-names>D</given-names></name><name><surname>Waruiru</surname><given-names>C</given-names></name><name><surname>Mwangi</surname><given-names>I</given-names></name><name><surname>Winstanley</surname><given-names>M</given-names></name><name><surname>Marsh</surname><given-names>V</given-names></name><name><surname>Newton</surname><given-names>C</given-names></name><name><surname>Winstanley</surname><given-names>P</given-names></name><name><surname>Warn</surname><given-names>P</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Indicators of life-threatening malaria in african children</article-title><source>The New England Journal of Medicine</source><volume>332</volume><fpage>1399</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1056/NEJM199505253322102</pub-id><pub-id pub-id-type="pmid">7723795</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Malaria transmission and morbidity</article-title><source>Parassitologia</source><volume>41</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">10697862</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrick</surname><given-names>CJ</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><name><surname>Buckee</surname><given-names>C</given-names></name><name><surname>Amambua-Ngwa</surname><given-names>A</given-names></name><name><surname>Gomez-Escobar</surname><given-names>N</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Conway</surname><given-names>DJ</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Epigenetic dysregulation of virulence gene expression in severe <italic>Plasmodium falciparum</italic> malaria</article-title><source>The Journal of Infectious Diseases</source><volume>205</volume><fpage>1593</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis239</pub-id><pub-id pub-id-type="pmid">22448008</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogeni</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Fegan</surname><given-names>G</given-names></name><name><surname>Nyundo</surname><given-names>C</given-names></name><name><surname>Bauni</surname><given-names>E</given-names></name><name><surname>Mwai</surname><given-names>K</given-names></name><name><surname>Omedo</surname><given-names>I</given-names></name><name><surname>Njuguna</surname><given-names>P</given-names></name><name><surname>Newton</surname><given-names>CR</given-names></name><name><surname>Osier</surname><given-names>F</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Hammitt</surname><given-names>LL</given-names></name><name><surname>Lowe</surname><given-names>B</given-names></name><name><surname>Mwambingu</surname><given-names>G</given-names></name><name><surname>Awuondo</surname><given-names>K</given-names></name><name><surname>Mturi</surname><given-names>N</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Age, spatial, and temporal variations in hospital admissions with malaria in kilifi county, kenya: a 25-year longitudinal observational study</article-title><source>PLOS Medicine</source><volume>13</volume><elocation-id>e1002047</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002047</pub-id><pub-id pub-id-type="pmid">27352303</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njuguna</surname><given-names>P</given-names></name><name><surname>Maitland</surname><given-names>K</given-names></name><name><surname>Nyaguara</surname><given-names>A</given-names></name><name><surname>Mwanga</surname><given-names>D</given-names></name><name><surname>Mogeni</surname><given-names>P</given-names></name><name><surname>Mturi</surname><given-names>N</given-names></name><name><surname>Mohammed</surname><given-names>S</given-names></name><name><surname>Mwambingu</surname><given-names>G</given-names></name><name><surname>Ngetsa</surname><given-names>C</given-names></name><name><surname>Awuondo</surname><given-names>K</given-names></name><name><surname>Lowe</surname><given-names>B</given-names></name><name><surname>Adetifa</surname><given-names>I</given-names></name><name><surname>Scott</surname><given-names>JAG</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Atkinson</surname><given-names>S</given-names></name><name><surname>Osier</surname><given-names>F</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Tsofa</surname><given-names>B</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Hamaluba</surname><given-names>M</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Newton</surname><given-names>CRJ</given-names></name><name><surname>Fondo</surname><given-names>J</given-names></name><name><surname>Omar</surname><given-names>A</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Observational study: 27 years of severe malaria surveillance in kilifi, kenya</article-title><source>BMC Medicine</source><volume>17</volume><elocation-id>124</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-019-1359-9</pub-id><pub-id pub-id-type="pmid">31280724</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname><given-names>MSM</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Anantharaman</surname><given-names>V</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Mahajan</surname><given-names>B</given-names></name><name><surname>Haynes</surname><given-names>JD</given-names></name><name><surname>Moch</surname><given-names>JK</given-names></name><name><surname>Fairhurst</surname><given-names>R</given-names></name><name><surname>McCutchan</surname><given-names>TF</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular factors and biochemical pathways induced by febrile temperature in intraerythrocytic <italic>Plasmodium falciparum</italic> parasites</article-title><source>Infection and Immunity</source><volume>75</volume><fpage>2012</fpage><lpage>2025</lpage><pub-id pub-id-type="doi">10.1128/IAI.01236-06</pub-id><pub-id pub-id-type="pmid">17283083</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Meara</surname><given-names>WP</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Mwangi</surname><given-names>TW</given-names></name><name><surname>Okiro</surname><given-names>EA</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Newton</surname><given-names>C</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effect of a fall in malaria transmission on morbidity and mortality in kilifi, kenya</article-title><source>Lancet</source><volume>372</volume><fpage>1555</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)61655-4</pub-id><pub-id pub-id-type="pmid">18984188</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>OM</given-names></name><name><surname>Carmona</surname><given-names>JJ</given-names></name><name><surname>Michan</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>KY</given-names></name><name><surname>Manabe</surname><given-names>Y</given-names></name><name><surname>Ward</surname><given-names>JL</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name><name><surname>Tong</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle</article-title><source>Aging</source><volume>1</volume><fpage>771</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.18632/aging.100075</pub-id><pub-id pub-id-type="pmid">20157566</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation</article-title><source>Cellular Immunology</source><volume>289</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2014.04.010</pub-id><pub-id pub-id-type="pmid">24841857</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawat</surname><given-names>M</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Johri</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>I</given-names></name><name><surname>Karmodiya</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell RNA sequencing reveals cellular heterogeneity and stage transition under temperature stress in synchronized <italic>Plasmodium falciparum</italic> cells</article-title><source>Microbiology Spectrum</source><volume>9</volume><elocation-id>e0000821</elocation-id><pub-id pub-id-type="doi">10.1128/Spectrum.00008-21</pub-id><pub-id pub-id-type="pmid">34232098</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recker</surname><given-names>M</given-names></name><name><surname>Nee</surname><given-names>S</given-names></name><name><surname>Bull</surname><given-names>PC</given-names></name><name><surname>Kinyanjui</surname><given-names>S</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Newbold</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Transient cross-reactive immune responses can orchestrate antigenic variation in malaria</article-title><source>Nature</source><volume>429</volume><fpage>555</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1038/nature02486</pub-id><pub-id pub-id-type="pmid">15175751</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>A</given-names></name><name><surname>Rudnitskaya</surname><given-names>A</given-names></name><name><surname>Blackburn</surname><given-names>GJ</given-names></name><name><surname>Fauzi</surname><given-names>NM</given-names></name><name><surname>Pitt</surname><given-names>AR</given-names></name><name><surname>Spickett</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL</article-title><source>Journal of Lipid Research</source><volume>54</volume><fpage>1812</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.1194/jlr.M034330</pub-id><pub-id pub-id-type="pmid">23670529</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rono</surname><given-names>MK</given-names></name><name><surname>Nyonda</surname><given-names>MA</given-names></name><name><surname>Simam</surname><given-names>JJ</given-names></name><name><surname>Ngoi</surname><given-names>JM</given-names></name><name><surname>Mok</surname><given-names>S</given-names></name><name><surname>Kortok</surname><given-names>MM</given-names></name><name><surname>Abdullah</surname><given-names>AS</given-names></name><name><surname>Elfaki</surname><given-names>MM</given-names></name><name><surname>Waitumbi</surname><given-names>JN</given-names></name><name><surname>El-Hassan</surname><given-names>IM</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Bozdech</surname><given-names>Z</given-names></name><name><surname>Mackinnon</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adaptation of <italic>Plasmodium falciparum</italic> to its transmission environment</article-title><source>Nature Ecology &amp; Evolution</source><volume>2</volume><fpage>377</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1038/s41559-017-0419-9</pub-id><pub-id pub-id-type="pmid">29255304</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottmann</surname><given-names>M</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Mugasa</surname><given-names>JP</given-names></name><name><surname>Kaestli</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>ATR</given-names></name><name><surname>Müller</surname><given-names>D</given-names></name><name><surname>Theander</surname><given-names>T</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differential expression of var gene groups is associated with morbidity caused by <italic>Plasmodium falciparum</italic> infection in tanzanian children</article-title><source>Infection and Immunity</source><volume>74</volume><fpage>3904</fpage><lpage>3911</lpage><pub-id pub-id-type="doi">10.1128/IAI.02073-05</pub-id><pub-id pub-id-type="pmid">16790763</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>JA</given-names></name><name><surname>Claessens</surname><given-names>A</given-names></name><name><surname>Corrigan</surname><given-names>RA</given-names></name><name><surname>Arman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Adhesion of <italic>Plasmodium falciparum</italic>-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications</article-title><source>Expert Reviews in Molecular Medicine</source><volume>11</volume><elocation-id>e16</elocation-id><pub-id pub-id-type="doi">10.1017/S1462399409001082</pub-id><pub-id pub-id-type="pmid">19467172</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salanti</surname><given-names>A</given-names></name><name><surname>Staalsoe</surname><given-names>T</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Jensen</surname><given-names>ATR</given-names></name><name><surname>Sowa</surname><given-names>MPK</given-names></name><name><surname>Arnot</surname><given-names>DE</given-names></name><name><surname>Hviid</surname><given-names>L</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering <italic>Plasmodium falciparum</italic> involved in pregnancy-associated malaria</article-title><source>Molecular Microbiology</source><volume>49</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03570.x</pub-id><pub-id pub-id-type="pmid">12823820</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheltema</surname><given-names>RA</given-names></name><name><surname>Jankevics</surname><given-names>A</given-names></name><name><surname>Jansen</surname><given-names>RC</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Breitling</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PeakML/mzmatch: a file format, java library, R library, and tool-chain for mass spectrometry data analysis</article-title><source>Analytical Chemistry</source><volume>83</volume><fpage>2786</fpage><lpage>2793</lpage><pub-id pub-id-type="doi">10.1021/ac2000994</pub-id><pub-id pub-id-type="pmid">21401061</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherf</surname><given-names>A</given-names></name><name><surname>Lopez-Rubio</surname><given-names>JJ</given-names></name><name><surname>Riviere</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Antigenic variation in <italic>Plasmodium falciparum</italic></article-title><source>Annual Review of Microbiology</source><volume>62</volume><fpage>445</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.61.080706.093134</pub-id><pub-id pub-id-type="pmid">18785843</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapouri-Moghaddam</surname><given-names>A</given-names></name><name><surname>Mohammadian</surname><given-names>S</given-names></name><name><surname>Vazini</surname><given-names>H</given-names></name><name><surname>Taghadosi</surname><given-names>M</given-names></name><name><surname>Esmaeili</surname><given-names>SA</given-names></name><name><surname>Mardani</surname><given-names>F</given-names></name><name><surname>Seifi</surname><given-names>B</given-names></name><name><surname>Mohammadi</surname><given-names>A</given-names></name><name><surname>Afshari</surname><given-names>JT</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Macrophage plasticity, polarization, and function in health and disease</article-title><source>Journal of Cellular Physiology</source><volume>233</volume><fpage>6425</fpage><lpage>6440</lpage><pub-id pub-id-type="doi">10.1002/jcp.26429</pub-id><pub-id pub-id-type="pmid">29319160</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silamut</surname><given-names>K</given-names></name><name><surname>Phu</surname><given-names>NH</given-names></name><name><surname>Whitty</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>GD</given-names></name><name><surname>Louwrier</surname><given-names>K</given-names></name><name><surname>Mai</surname><given-names>NT</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Hien</surname><given-names>TT</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain</article-title><source>The American Journal of Pathology</source><volume>155</volume><fpage>395</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)65136-X</pub-id><pub-id pub-id-type="pmid">10433933</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>KR</given-names></name><name><surname>Modrzynska</surname><given-names>KK</given-names></name><name><surname>Otto</surname><given-names>TD</given-names></name><name><surname>Pfander</surname><given-names>C</given-names></name><name><surname>Dickens</surname><given-names>NJ</given-names></name><name><surname>Religa</surname><given-names>AA</given-names></name><name><surname>Bushell</surname><given-names>E</given-names></name><name><surname>Graham</surname><given-names>AL</given-names></name><name><surname>Cameron</surname><given-names>R</given-names></name><name><surname>Kafsack</surname><given-names>BFC</given-names></name><name><surname>Williams</surname><given-names>AE</given-names></name><name><surname>Llinas</surname><given-names>M</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Billker</surname><given-names>O</given-names></name><name><surname>Waters</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A cascade of DNA-binding proteins for sexual commitment and development in plasmodium</article-title><source>Nature</source><volume>507</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/nature12970</pub-id><pub-id pub-id-type="pmid">24572359</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Chitnis</surname><given-names>CE</given-names></name><name><surname>Craig</surname><given-names>AG</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Hudson-Taylor</surname><given-names>DE</given-names></name><name><surname>Peterson</surname><given-names>DS</given-names></name><name><surname>Pinches</surname><given-names>R</given-names></name><name><surname>Newbold</surname><given-names>CI</given-names></name><name><surname>Miller</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Switches in expression of <italic>Plasmodium falciparum</italic> var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes</article-title><source>Cell</source><volume>82</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90056-x</pub-id><pub-id pub-id-type="pmid">7606775</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>Want</surname><given-names>EJ</given-names></name><name><surname>O’Maille</surname><given-names>G</given-names></name><name><surname>Abagyan</surname><given-names>R</given-names></name><name><surname>Siuzdak</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification</article-title><source>Analytical Chemistry</source><volume>78</volume><fpage>779</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1021/ac051437y</pub-id><pub-id pub-id-type="pmid">16448051</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorci</surname><given-names>G</given-names></name><name><surname>Léchenault-Bergerot</surname><given-names>C</given-names></name><name><surname>Faivre</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Age reduces resistance and tolerance in malaria-infected mice</article-title><source>Infection, Genetics and Evolution</source><volume>88</volume><elocation-id>104698</elocation-id><pub-id pub-id-type="doi">10.1016/j.meegid.2020.104698</pub-id><pub-id pub-id-type="pmid">33370596</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>XZ</given-names></name><name><surname>Heatwole</surname><given-names>VM</given-names></name><name><surname>Wertheimer</surname><given-names>SP</given-names></name><name><surname>Guinet</surname><given-names>F</given-names></name><name><surname>Herrfeldt</surname><given-names>JA</given-names></name><name><surname>Peterson</surname><given-names>DS</given-names></name><name><surname>Ravetch</surname><given-names>JA</given-names></name><name><surname>Wellems</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of <italic>Plasmodium falciparum</italic>-infected erythrocytes</article-title><source>Cell</source><volume>82</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90055-1</pub-id><pub-id pub-id-type="pmid">7606788</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>JL</given-names></name><name><surname>Lash</surname><given-names>B</given-names></name><name><surname>Karami</surname><given-names>R</given-names></name><name><surname>Nayer</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>YZ</given-names></name><name><surname>Piotto</surname><given-names>C</given-names></name><name><surname>Julier</surname><given-names>Z</given-names></name><name><surname>Martino</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist</article-title><source>Communications Biology</source><volume>4</volume><elocation-id>422</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-01913-9</pub-id><pub-id pub-id-type="pmid">33772102</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>TE</given-names></name><name><surname>Fu</surname><given-names>WJ</given-names></name><name><surname>Carr</surname><given-names>RA</given-names></name><name><surname>Whitten</surname><given-names>RO</given-names></name><name><surname>Mueller</surname><given-names>JS</given-names></name><name><surname>Fosiko</surname><given-names>NG</given-names></name><name><surname>Lewallen</surname><given-names>S</given-names></name><name><surname>Liomba</surname><given-names>NG</given-names></name><name><surname>Molyneux</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Differentiating the pathologies of cerebral malaria by postmortem parasite counts</article-title><source>Nature Medicine</source><volume>10</volume><fpage>143</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1038/nm986</pub-id><pub-id pub-id-type="pmid">14745442</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonkin</surname><given-names>CJ</given-names></name><name><surname>Carret</surname><given-names>CK</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name><name><surname>Voss</surname><given-names>TS</given-names></name><name><surname>Ralph</surname><given-names>SA</given-names></name><name><surname>Hommel</surname><given-names>M</given-names></name><name><surname>Duffy</surname><given-names>MF</given-names></name><name><surname>Silva</surname><given-names>L da</given-names></name><name><surname>Scherf</surname><given-names>A</given-names></name><name><surname>Ivens</surname><given-names>A</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><name><surname>Beeson</surname><given-names>JG</given-names></name><name><surname>Cowman</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in <italic>Plasmodium falciparum</italic></article-title><source>PLOS Biology</source><volume>7</volume><elocation-id>e84</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000084</pub-id><pub-id pub-id-type="pmid">19402747</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Berger</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Petersen</surname><given-names>JEV</given-names></name><name><surname>Avril</surname><given-names>M</given-names></name><name><surname>Brazier</surname><given-names>AJ</given-names></name><name><surname>Freeth</surname><given-names>J</given-names></name><name><surname>Jespersen</surname><given-names>JS</given-names></name><name><surname>Nielsen</surname><given-names>MA</given-names></name><name><surname>Magistrado</surname><given-names>P</given-names></name><name><surname>Lusingu</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Higgins</surname><given-names>MK</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Severe malaria is associated with parasite binding to endothelial protein C receptor</article-title><source>Nature</source><volume>498</volume><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/nature12216</pub-id><pub-id pub-id-type="pmid">23739325</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usui</surname><given-names>M</given-names></name><name><surname>Prajapati</surname><given-names>SK</given-names></name><name><surname>Ayanful-Torgby</surname><given-names>R</given-names></name><name><surname>Acquah</surname><given-names>FK</given-names></name><name><surname>Cudjoe</surname><given-names>E</given-names></name><name><surname>Kakaney</surname><given-names>C</given-names></name><name><surname>Amponsah</surname><given-names>JA</given-names></name><name><surname>Obboh</surname><given-names>EK</given-names></name><name><surname>Reddy</surname><given-names>DK</given-names></name><name><surname>Barbeau</surname><given-names>MC</given-names></name><name><surname>Simons</surname><given-names>LM</given-names></name><name><surname>Czesny</surname><given-names>B</given-names></name><name><surname>Raiciulescu</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>C</given-names></name><name><surname>Abuaku</surname><given-names>BK</given-names></name><name><surname>Amoah</surname><given-names>LE</given-names></name><name><surname>Williamson</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Publisher correction: <italic>Plasmodium falciparum</italic> sexual differentiation in malaria patients is associated with host factors and GDV1-dependent genes</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2740</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10805-w</pub-id><pub-id pub-id-type="pmid">31227704</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasquez</surname><given-names>MC</given-names></name><name><surname>Beam</surname><given-names>M</given-names></name><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>Zuzow</surname><given-names>MJ</given-names></name><name><surname>Tomanek</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sirtuins regulate proteomic responses near thermal tolerance limits in the blue mussels mytilus galloprovincialis and <italic>Mytilus trossulus</italic></article-title><source>The Journal of Experimental Biology</source><volume>220</volume><fpage>4515</fpage><lpage>4534</lpage><pub-id pub-id-type="doi">10.1242/jeb.160325</pub-id><pub-id pub-id-type="pmid">29025872</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>ES</given-names></name><name><surname>Girard-Guyonvarc’h</surname><given-names>C</given-names></name><name><surname>Holzinger</surname><given-names>D</given-names></name><name><surname>de Jesus</surname><given-names>AA</given-names></name><name><surname>Tariq</surname><given-names>Z</given-names></name><name><surname>Picarsic</surname><given-names>J</given-names></name><name><surname>Schiffrin</surname><given-names>EJ</given-names></name><name><surname>Foell</surname><given-names>D</given-names></name><name><surname>Grom</surname><given-names>AA</given-names></name><name><surname>Ammann</surname><given-names>S</given-names></name><name><surname>Ehl</surname><given-names>S</given-names></name><name><surname>Hoshino</surname><given-names>T</given-names></name><name><surname>Goldbach-Mansky</surname><given-names>R</given-names></name><name><surname>Gabay</surname><given-names>C</given-names></name><name><surname>Canna</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome</article-title><source>Blood</source><volume>131</volume><fpage>1442</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-12-820852</pub-id><pub-id pub-id-type="pmid">29326099</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Anaemia and malaria</article-title><source>Malaria Journal</source><volume>17</volume><elocation-id>371</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-018-2509-9</pub-id><pub-id pub-id-type="pmid">30340592</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="report"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2022">2022</year><source>World malaria Report</source><publisher-name>WHO</publisher-name></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Stimulation of <italic>Plasmodium falciparum</italic> gametocytogenesis by conditioned medium from parasite cultures</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>60</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1999.60.7</pub-id><pub-id pub-id-type="pmid">9988315</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>T’Kind</surname><given-names>R</given-names></name><name><surname>Decuypere</surname><given-names>S</given-names></name><name><surname>von Freyend</surname><given-names>SJ</given-names></name><name><surname>Coombs</surname><given-names>GH</given-names></name><name><surname>Watson</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Profiling of lipids in leishmania donovani using hydrophilic interaction chromatography in combination with fourier transform mass spectrometry</article-title><source>Rapid Communications in Mass Spectrometry</source><volume>24</volume><fpage>2074</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1002/rcm.4618</pub-id><pub-id pub-id-type="pmid">20552712</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>AY</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Deitsch</surname><given-names>KW</given-names></name><name><surname>Hao</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title><italic>Plasmodium falciparum</italic> sir2a preferentially hydrolyzes medium and long chain fatty acyl lysine</article-title><source>ACS Chemical Biology</source><volume>7</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1021/cb200230x</pub-id><pub-id pub-id-type="pmid">21992006</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85140.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.11.29.518379" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.29.518379"/></front-stub><body><p>This important work provides insight into how <italic>Plasmodium falciparum</italic> optimises the balance between infection of the human host and investment in onward transmission to the mosquito. The results, based on appropriate and validated state-of-the-art methodologies, are convincing and have both theoretical and practical implications beyond a single subfield.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85140.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0145znz58</institution-id><institution>Walter Reed Army Institute of Research</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Delves</surname><given-names>Michael</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00a0jsq62</institution-id><institution>London School of Hygiene &amp; Tropical Medicine</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Moon</surname><given-names>Robert William</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00a0jsq62</institution-id><institution>London School of Hygiene &amp; Tropical Medicine</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.29.518379">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.11.29.518379v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>Plasmodium falciparum</italic> adapts its investment into replication versus transmission according to the host environment&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Dominique Soldati-Favre as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Michael Delves (Reviewer #1); Robert William Moon (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>1. Please respond to the Reviewers' comments concerning issues that require clarifications/revisions of the text, selected figures (e.g., Figure 2, 4), and figure legends.</p><p>2. Please include data that shows a lack of correlation between pfs16 and another gene that is not involved in gametocytes/sexual commitment.</p><p>3. Please revisit your statistical analyses as suggested.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>I am not an expert in quantitative transcriptomics and lipidomics, however, the study appears to be well-designed, appropriately powered, and with appropriate controls and conclusions.</p><p>Line 35 – Please cite data from the most recent World Malaria Report.</p><p>Line 88 – Please explain how the 552 samples were selected. Was it at random?</p><p>Line 105 – Figure 2A and B both have three graphs. It would be helpful in the text to be clear when discussing the data, which graph in each panel is being referred to (i.e. left, middle, right).</p><p>Line 112 – &quot;This association validates ap2-g as a proxy for both, stage conversion and gametocyte levels.&quot; This is likely the case, but the data presented here only shows ap2-g and Pfsir2a compared to pfs16. Do all genes show this positive correlation? The data would be strengthened by showing the (non)correlation between pfs16 and another gene not known to be involved in gametocytes/sexual commitment just to confirm that data observed is specific.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. Most of the figures lack explanatory assays and are based on selected correlations. The authors should consider adding to the discussion not only a model but also ways to validate the model, to avoid misinterpretation of the results due to underlying causations.</p><p>2. Figure 1C, D lines 104-106: It is unclear why these sub-figures refer to outpatients as they describe the admissions. Please clarify.</p><p>3. Figure 2A lines 102-103: &quot;For this purpose, we measured both total parasite biomass based on PfHRP2 levels and peripheral parasitemia based on parasite counts from blood smears&quot;. The authors should better explain how they linked PfHRP2 to the parasites' biomass. If the goal was to assess parasitemia in a different way, please show the ratio between units of PfHRP2 and parasitemia levels. The link between the two might not be linear.</p><p>4. Figure 2 and 4: The authors should revisit their statistical analyses throughout the manuscript. This is a supercritical element in such a field study.</p><p>Please provide an explanation for why you chose to use the Wilcoxon test for pair-wise comparisons. The Wilcoxson test is for non-parametric data; please demonstrate that the data does not distribute normally, for example, using the Shapiro-Wilk test. Furthermore, multiple comparisons for multifactorial data are usually done using multifactorial ANOVA analysis (more robust for false-positive errors).</p><p>5. Figure 2F: It is unclear, and again not explained, what are the described subgroups.</p><p>6. Figure 3: The figure legend does not note which correlation test was used. Please see major comment #4 and consider revising/explaining why you used the Wilcoxson test to analyze multifactorial data rather than a multifactorial ANOVA analysis. The authors should briefly explain the idea behind factorial analysis, as it will make the results clearer. For example, factor analysis is a derivative of the widely used PCA analysis for clustering multidimensional data.</p><p>7. Figure 4A: It is noted in the text that group F5 has a positive association with LPC.</p><p>However, according to the color-coding in the figure, the correlation appears to be closer to zero – again, a very odd interpretation.</p><p>8. Figure 4B: The explanation provided in the figure legend is unclear.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>I am still not entirely clear on the description of the data from 4c-e, and they could be misinterpreted. The sentence &quot;Indeed, LPC species showed a negative association with both ap2-g and Pfsir2a transcription levels (Figure 4C-E). The association was only significant in our data when inflammation is highest (and LPC level lowest), which is at low transmission (i.e., post decline).&quot; Suggests there is a trend in both, with only post-decline significant. In fact, the predecline shows a non-significant positive correlation between AP2G and LPC so it's really quite different from the pattern seen post-decline. These sentences and discussion (L217) could be adjusted to make this clearer.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85140.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>I am not an expert in quantitative transcriptomics and lipidomics, however, the study appears to be well-designed, appropriately powered, and with appropriate controls and conclusions.</p><p>Line 35 – Please cite data from the most recent World Malaria Report.</p></disp-quote><p>The numbers have been updated according to the WHO report from 2022.</p><disp-quote content-type="editor-comment"><p>Line 88 – Please explain how the 552 samples were selected. Was it at random?</p></disp-quote><p>The 552 samples were pragmatically selected so that the sample size is within available budget but the only consideration for inclusion was the clinical phenotype and transmission period so that the various clinical phenotypes and transmission period are adequately represented (Figure 1). This is noted in line 88f:</p><p>“552 of the admissions were pragmatically selected to ensure adequate sampling of the transmission periods and clinical phenotypes (Figure 1C).”</p><disp-quote content-type="editor-comment"><p>Line 105 – Figure 2A and B both have three graphs. It would be helpful in the text to be clear when discussing the data, which graph in each panel is being referred to (i.e. left, middle, right).</p></disp-quote><p>We have clarified this in the text.</p><disp-quote content-type="editor-comment"><p>Line 112 – &quot;This association validates ap2-g as a proxy for both, stage conversion and gametocyte levels.&quot; This is likely the case, but the data presented here only shows ap2-g and Pfsir2a compared to pfs16. Do all genes show this positive correlation? The data would be strengthened by showing the (non)correlation between pfs16 and another gene not known to be involved in gametocytes/sexual commitment just to confirm that data observed is specific.</p></disp-quote><p>We would like to thank reviewer #1 for this important point. We are using the combination of two housekeeping genes (seryl tRNA synthetase, fructose biphosphate aldolase) to normalise all markers analysed (<italic>ap2-g</italic>, <italic>Pfsir2a</italic> and <italic>Pfs16</italic>, and <italic>var</italic> gene groups). We have now introduced an additional supplementary figure (Figure 3 —figure supplement 1) representing expression correlation of all three genes (<italic>ap2-g</italic>, <italic>Pfsir2a</italic> and <italic>Pfs16</italic>) with <italic>var</italic> gene groups. Indeed, <italic>Pfs16</italic> is only correlated with <italic>var</italic> groups B1 and C1 demonstrating that there is no systematic bias in the qRT-PCR data.</p><p>We have added the following text in the result section:</p><p>“To ensure that there is no systematic bias in the qRT-PCR data we also tested the association of <italic>Pfs16</italic> expression against <italic>var</italic> gene subgroups. <italic>Pfs16</italic> expression showed a significant positive correlation with group B (here termed gpb1) and C (gpc2) <italic>var</italic> genes, while no correlation was observed with the rest of the <italic>var</italic> subgroups (Figure 3 —figure supplement 1).”</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. Most of the figures lack explanatory assays and are based on selected correlations. The authors should consider adding to the discussion not only a model but also ways to validate the model, to avoid misinterpretation of the results due to underlying causations.</p></disp-quote><p>That is a great suggestion and we have added a phrase to the discussion accordingly.</p><p>“We anticipate that the proposed model could be tested in controlled human malaria infections with malaria naïve and semi-immune participants as a proxy for low vs high transmission settings.”</p><disp-quote content-type="editor-comment"><p>2. Figure 1C, D lines 104-106: It is unclear why these sub-figures refer to outpatients as they describe the admissions. Please clarify.</p></disp-quote><p>Patient groups (admissions, outpatients and asymptomatics) and the clinical subgroups are all shown in Figure 1. The definition of these groups is included in the methods section under clinical definitions.</p><disp-quote content-type="editor-comment"><p>3. Figure 2A lines 102-103: &quot;For this purpose, we measured both total parasite biomass based on PfHRP2 levels and peripheral parasitemia based on parasite counts from blood smears&quot;. The authors should better explain how they linked PfHRP2 to the parasites' biomass. If the goal was to assess parasitemia in a different way, please show the ratio between units of PfHRP2 and parasitemia levels. The link between the two might not be linear.</p></disp-quote><p>PfHRP2 has long been used as a more accurate marker for parasite biomass than peripheral parasitemia, both in <italic>P. falciparum</italic> (Dondorp <italic>et al.</italic>, PLoS Med, 2005; Marquart <italic>et al.</italic>, Mal J 2022) and in <italic>P. vivax</italic> (Barber <italic>et al.</italic> PLoS Path 2015, Silva Filho <italic>et al. eLife</italic> 2021) as PfHRP2 is secreted by sequestered and circulating parasites. As this reviewer notes the association between PfHRP2 and peripheral parasitemia is not necessarily linear (see references above).</p><p>We have added the original reference (Dondorp <italic>et al.</italic>, PLoS Med 2005) to the text.</p><disp-quote content-type="editor-comment"><p>4. Figure 2 and 4: The authors should revisit their statistical analyses throughout the manuscript. This is a supercritical element in such a field study.</p><p>Please provide an explanation for why you chose to use the Wilcoxon test for pair-wise comparisons. The Wilcoxson test is for non-parametric data; please demonstrate that the data does not distribute normally, for example, using the Shapiro-Wilk test. Furthermore, multiple comparisons for multifactorial data are usually done using multifactorial ANOVA analysis (more robust for false-positive errors).</p></disp-quote><p>Generally, non-parametric tests are less powerful but more robust. We chose non-parametric tests since they are not affected by outliers as the variables do not perfectly follow normal distribution. Ttest produces similar result as Wilcoxon test. However, we used a parametric test (regression) where we needed to adjust for potential confounders such as transmission period, age etc (Figures 3 and 4).</p><disp-quote content-type="editor-comment"><p>5. Figure 2F: It is unclear, and again not explained, what are the described subgroups.</p></disp-quote><p>We included more details explaining the <italic>var</italic> subgroups in the figure legend.</p><disp-quote content-type="editor-comment"><p>6. Figure 3: The figure legend does not note which correlation test was used. Please see major comment #4 and consider revising/explaining why you used the Wilcoxson test to analyze multifactorial data rather than a multifactorial ANOVA analysis. The authors should briefly explain the idea behind factorial analysis, as it will make the results clearer. For example, factor analysis is a derivative of the widely used PCA analysis for clustering multidimensional data.</p></disp-quote><p>Both PCA and factor analysis are used to reduce high dimensional data, but factor analysis assumes that an interpretable latent variable (factor) explains the correlation between variables. For this reason, we attempted to assign the factors to biological function (line 148-152), and this is important in understanding the data presented in figure 3 and 4. We also used the data in structural equation modelling which relies on factor analysis.</p><disp-quote content-type="editor-comment"><p>7. Figure 4A: It is noted in the text that group F5 has a positive association with LPC.</p><p>However, according to the color-coding in the figure, the correlation appears to be closer to zero – again, a very odd interpretation.</p></disp-quote><p>F5 association with the lipids has been done via a linear regression and associated statistic. Only one LysoPC species is significantly associated with F5 (LysoPC 18:2). This has been clarified in the manuscript and the associated statistics are now provided in supplementary file 2.</p><p>The following phrase has been edited accordingly:</p><p>“F5 showed significant positive association with one LPC species and negative associations with PC, respectively, while F4 showed significant negative association with three LPC species (Figure 4A, supplementary file 2).”</p><disp-quote content-type="editor-comment"><p>8. Figure 4B: The explanation provided in the figure legend is unclear.</p></disp-quote><p>We have added more detail to the annotation of this graph.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>I am still not entirely clear on the description of the data from 4c-e, and they could be misinterpreted. The sentence &quot;Indeed, LPC species showed a negative association with both ap2-g and Pfsir2a transcription levels (Figure 4C-E). The association was only significant in our data when inflammation is highest (and LPC level lowest), which is at low transmission (i.e., post decline).&quot; Suggests there is a trend in both, with only post-decline significant. In fact, the predecline shows a non-significant positive correlation between AP2G and LPC so it's really quite different from the pattern seen post-decline. These sentences and discussion (L217) could be adjusted to make this clearer.</p></disp-quote><p>We agree with this reviewer that the data in Figure 4C-E need clarification. Further analysis revealed that LPC levels are highest and vary little across patients at high transmission (pre decline). This lack of variation likely explains the lack of association with <italic>ap2-g</italic> transcription levels in the pre decline period. We have added a new panel in Figure 4D and text in the result section.</p><p>“In contrast, LPC levels are highest and vary little across patients at high transmission (pre decline).”</p><p>A new figure legend has been added accordingly:</p><p>“Distribution of <italic>ap2-g</italic> transcript levels (left) and LysoPC (16:0) intensity (right) across patients and stratified by transmission period. Data are corrected for age and <italic>Pf</italic>HRP2.”</p></body></sub-article></article>